sockbuster的个人主页 - 老虎社区

sockbuster

sockbuster

暂无个人介绍

IP属地：未知

334关注

14粉丝

0主题

0勋章

2021-12-25

Pls like

抱歉，原内容已删除

2021-12-23

Pls like

Wall St mints strong gains on rosy economic data, encouraging Omicron update

2021-12-22

Pls like

Toplines Before US Market Open on Wednesday

2021-12-21

Pls like

China Online Education Group Announces Receipt of NYSE Non-Compliance Letter

2021-12-19

Pls like

Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade

2021-12-16

Pls like

Tilray Makes Another Key Acquisition in the U.S.

2021-12-15

Pls like

1 Unstoppable Vanguard ETF That Could Double Your Money in 2022

2021-12-14

Pls like

Got $1,500? 3 Growth Stocks to Buy That Could Double Your Money

2021-12-13

Pls like

Toplines Before US Market Open on Monday

2021-12-12

Pls like

US IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week

2021-12-09

Pls like

EV stocks fell in morning trading

2021-12-08

Pls like

抱歉，原内容已删除

2021-12-06

Pls like

Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week

2021-12-03

Pls like

Fastly stock climbed nearly 5% in premarket trading

2021-12-01

Pls like

抱歉，原内容已删除

2021-11-30

Pls like

5 Stocks To Watch For November 30, 2021

2021-11-29

Pls like

5 Stocks To Watch For November 29, 2021

2021-11-26

Pls like

All Eyes on U.S. Opening as Global Rout Spreads: Markets Wrap

2021-11-25

Pls like

Wall Street ends higher; Nvidia surge offsets Nordstrom, Gap slide

2021-11-24

Pls like

FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3580889175020769","uuid":"3580889175020769","gmtCreate":1617795152135,"gmtModify":1627995458924,"name":"sockbuster","pinyin":"sockbuster","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":14,"headSize":334,"tweetSize":89,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":698273527,"gmtCreate":1640426196986,"gmtModify":1640426732815,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698273527","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":1642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691758902,"gmtCreate":1640249664642,"gmtModify":1640249664892,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691758902","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://ttm.financial/m/news/2193113147?lang=&edition=full","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞",".IXIC":"NASDAQ Composite","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","TSLA":"特斯拉",".DJI":"道琼斯","BK4568":"美国抗疫概念","COMP":"Compass, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,"COMP":0.6,"PFE":0.9,"TSLA":0.6}},"isVote":1,"tweetType":1,"viewCount":1694,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691693542,"gmtCreate":1640179454094,"gmtModify":1640179454686,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691693542","repostId":"1158577227","repostType":4,"repost":{"id":"1158577227","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640178165,"share":"https://ttm.financial/m/news/1158577227?lang=&edition=full","pubTime":"2021-12-22 21:02","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158577227","media":"Tiger Newspress","summary":"U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally","content":"<p>U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.</p>\n<p>At 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&amp;P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/512d5749bf54708c7063a6e721fa99f2\" tg-width=\"960\" tg-height=\"329\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p>Wall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&amp;P 500 index&nbsp;is up roughly 24% in 2021.</p>\n<p>Investors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/KMX\">CarMax</a> (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.</p>\n<p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a> (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.</p>\n<p><a href=\"https://laohu8.com/S/CAT\">Caterpillar</a> (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.</p>\n<p><a href=\"https://laohu8.com/S/CAMP\">CalAmp</a> (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.</p>\n<p><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a> (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a> (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.</p>\n<p><a href=\"https://laohu8.com/S/COIN\">Coinbase Global, Inc.</a> (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-22 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.</p>\n<p>At 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&amp;P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/512d5749bf54708c7063a6e721fa99f2\" tg-width=\"960\" tg-height=\"329\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p>Wall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&amp;P 500 index&nbsp;is up roughly 24% in 2021.</p>\n<p>Investors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/KMX\">CarMax</a> (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.</p>\n<p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a> (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.</p>\n<p><a href=\"https://laohu8.com/S/CAT\">Caterpillar</a> (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.</p>\n<p><a href=\"https://laohu8.com/S/CAMP\">CalAmp</a> (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.</p>\n<p><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a> (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a> (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.</p>\n<p><a href=\"https://laohu8.com/S/COIN\">Coinbase Global, Inc.</a> (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158577227","content_text":"U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.\nAt 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.\n*Source From Tiger Trade, EST 08:00\nWall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&P 500 index is up roughly 24% in 2021.\nInvestors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.\nStocks making the biggest moves in the premarket:\nCarMax (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.\nTesla Motors (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.\nBlackBerry (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.\nCaterpillar (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.\nCalAmp (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.\nAlibaba (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.\nDarden Restaurants (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.\nWilliams-Sonoma (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.\nCoinbase Global, Inc. (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.","news_type":1,"symbols_score_info":{".DJI":0,".IXIC":0,".SPX":0,"ESmain":0,"NQmain":0,"YMmain":0}},"isVote":1,"tweetType":1,"viewCount":2376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693726308,"gmtCreate":1640084750823,"gmtModify":1640084751192,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693726308","repostId":"2193598841","repostType":4,"repost":{"id":"2193598841","kind":"news","pubTimestamp":1640084400,"share":"https://ttm.financial/m/news/2193598841?lang=&edition=full","pubTime":"2021-12-21 19:00","market":"us","language":"en","title":"China Online Education Group Announces Receipt of NYSE Non-Compliance Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2193598841","media":"StreetInsider","summary":"SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"51Talk,\" or the \"Compa","content":"<p>SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"<a href=\"https://laohu8.com/S/COE\">51Talk</a>,\" or the \"Company\") (NYSE: COE) today announced that it has received a letter dated December 20, 2021 (the \"Letter\") from the New York Stock Exchange (the \"NYSE\"), notifying the Company that it is below compliance standards due to the Company's total market capitalization and stockholders' equity.</p>\n<p>Pursuant to applicable NYSE continued listing standards, a company would be considered \"below criteria\" by the NYSE if its total market capitalization is less than US$50 million over a 30 trading-day period and its stockholders' equity is less than US$50 million. A review of the current financial condition of the Company by the NYSE shows that, as of December 17, 2021, the Company's 30 trading-day average market capitalization was approximately US$39.3 million and its last reported stockholders' equity as of June 30, 2021 was approximately negative US$134.2 million. Accordingly, the Company is now subject to the procedures as set forth in Sections 801 and 802 of the NYSE Listed Company Manual, and is required to respond within 90 days of the Letter with a business plan that demonstrates compliance with the continued listing standard within 18 months of receipt of the Letter. The business plan will be reviewed for final disposition by the Listings Operations Committee of the NYSE.</p>\n<p>To address this issue, the Company intends to comply with the applicable procedures and is considering its options to regain compliance.</p>\n<p><b>Safe Harbor Statement</b></p>\n<p>This press release contains statements that may constitute \"forward-looking\" statements which are made pursuant to the \"safe harbor\" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as \"will,\" \"expects,\" \"anticipates,\" \"aims,\" \"future,\" \"intends,\" \"plans,\" \"believes,\" \"estimates,\" \"likely to,\" and similar statements. 51Talk may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (\"SEC\"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about 51Talk's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in 51Talk's filings with the SEC. All information provided in this press release is as of the date of this press release, and 51Talk does not undertake any obligation to update any forward-looking statement, except as required under applicable law.</p>\n<p><b>About China Online Education Group</b></p>\n<p>China Online Education Group (NYSE: COE) is a leading online education platform in China, with core expertise in English education. The Company's mission is to make quality education accessible and affordable. The Company's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Company connects its students with a large pool of highly qualified foreign teachers that it assembled using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students.</p>\n<p><b>For investor and media inquiries, please contact:</b></p>\n<p>China Online Education GroupInvestor Relationsir@51talk.com</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Online Education Group Announces Receipt of NYSE Non-Compliance Letter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Online Education Group Announces Receipt of NYSE Non-Compliance Letter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19376369><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"51Talk,\" or the \"Company\") (NYSE: COE) today announced that it has received a letter dated December 20, 2021 (the \"Letter\"...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19376369\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COE":"51TALK","BK4204":"教育服务"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19376369","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193598841","content_text":"SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"51Talk,\" or the \"Company\") (NYSE: COE) today announced that it has received a letter dated December 20, 2021 (the \"Letter\") from the New York Stock Exchange (the \"NYSE\"), notifying the Company that it is below compliance standards due to the Company's total market capitalization and stockholders' equity.\nPursuant to applicable NYSE continued listing standards, a company would be considered \"below criteria\" by the NYSE if its total market capitalization is less than US$50 million over a 30 trading-day period and its stockholders' equity is less than US$50 million. A review of the current financial condition of the Company by the NYSE shows that, as of December 17, 2021, the Company's 30 trading-day average market capitalization was approximately US$39.3 million and its last reported stockholders' equity as of June 30, 2021 was approximately negative US$134.2 million. Accordingly, the Company is now subject to the procedures as set forth in Sections 801 and 802 of the NYSE Listed Company Manual, and is required to respond within 90 days of the Letter with a business plan that demonstrates compliance with the continued listing standard within 18 months of receipt of the Letter. The business plan will be reviewed for final disposition by the Listings Operations Committee of the NYSE.\nTo address this issue, the Company intends to comply with the applicable procedures and is considering its options to regain compliance.\nSafe Harbor Statement\nThis press release contains statements that may constitute \"forward-looking\" statements which are made pursuant to the \"safe harbor\" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as \"will,\" \"expects,\" \"anticipates,\" \"aims,\" \"future,\" \"intends,\" \"plans,\" \"believes,\" \"estimates,\" \"likely to,\" and similar statements. 51Talk may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (\"SEC\"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about 51Talk's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in 51Talk's filings with the SEC. All information provided in this press release is as of the date of this press release, and 51Talk does not undertake any obligation to update any forward-looking statement, except as required under applicable law.\nAbout China Online Education Group\nChina Online Education Group (NYSE: COE) is a leading online education platform in China, with core expertise in English education. The Company's mission is to make quality education accessible and affordable. The Company's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Company connects its students with a large pool of highly qualified foreign teachers that it assembled using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students.\nFor investor and media inquiries, please contact:\nChina Online Education GroupInvestor Relationsir@51talk.com","news_type":1,"symbols_score_info":{"COE":0.9}},"isVote":1,"tweetType":1,"viewCount":2193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699700391,"gmtCreate":1639885504725,"gmtModify":1639885504895,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699700391","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://ttm.financial/m/news/1122414343?lang=&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p>\n<p>Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p>\n<p>Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p>\n<p><a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p>\n<p>Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p>\n<p>Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p>\n<p>Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p>\n<p>Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 11:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4568":"美国抗疫概念","CERN":"美国塞纳","BK4533":"AQR资本管理(全球第二大对冲基金)","ARNA":"阿里那","PFE":"辉瑞","ORCL":"甲骨文","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals  dominated with a ~83.8% rise after Pfizer  agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner  also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle  for the electronic-medical-records company.\nVaccine developer, Novavax  jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical  posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences  added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"ARNA":0.9,"CERN":0.9,"ORCL":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1513,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690860511,"gmtCreate":1639655295439,"gmtModify":1639655349507,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690860511","repostId":"2191910863","repostType":4,"repost":{"id":"2191910863","kind":"highlight","pubTimestamp":1639655142,"share":"https://ttm.financial/m/news/2191910863?lang=&edition=full","pubTime":"2021-12-16 19:45","market":"us","language":"en","title":"Tilray Makes Another Key Acquisition in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2191910863","media":"Motley Fool","summary":"Could there be even bigger moves ahead?","content":"<p>Cannabis producer&nbsp;<b>Tilray&nbsp;</b>(NASDAQ:TLRY) is among many Canadian businesses jockeying for position in the U.S. pot market, even though it isn't open just yet. One of the ways it can penetrate the market is through beverage companies that aren't currently selling cannabis-related products but could be leveraged to help enter the lucrative cannabis beverage market in the future. Plus, it gives the business a way to diversify its operations outside of marijuana.</p>\n<p>And that's what Tilray has done with yet another acquisition in the U.S. But will all this wheeling and dealing pay off, or could it lead to more challenges ahead for the business?</p>\n<h2>Acquisition of Breckenridge Distillery will open up more opportunities and add to Tilray's bottom line</h2>\n<p>On Dec. 8, Tilray announced that it would be acquiring Colorado-based Breckenridge Distillery, which it says is \"widely known for its award-winning bourbon whiskey collection and innovative craft spirits portfolio.\" There are two key aspects of note in the deal: First, the deal will be immediately accretive to the company's earnings before interest, taxes, depreciation and amortization (EBITDA), meaning Breckenridge's profits will reflect on Tilray's financial reporting as soon as the next quarter.</p>\n<p>Second, when it's legal to do so (i.e., when the U.S. legalizes marijuana at the federal level), it will allow Tilray to develop new products, including cannabis-infused whiskey.</p>\n<p>While the new opportunities are great, communicating profitability (on an adjusted EBITDA basis) is also essential. When the company released its first-quarter numbers for its fiscal 2022 in October, it marked the 10th consecutive period where Tilray posted an adjusted EBITDA profit, which is a streak it certainly doesn't want to interrupt. Moreover, maintaining a profit is one way Tilray can differentiate itself from other cannabis companies, many of which struggle with breaking even.</p>\n<h2>The move complements a broader strategy for Tilray</h2>\n<p>The beverage industry isn't a new target for Tilray. In Q1, it reported $15.5 million in revenue from alcoholic beverages from the SweetWater Brewing Company, which Aphria (which has since merged with Tilray) acquired last year. SweetWater is among the largest independent craft brewers in the U.S., and Tilray announced in November that it has entered the spirits category with the launch of two ready-to-drink cocktails. Tilray's interest in the cannabis beverage market goes back to 2018, when it announced a research partnership with Labatt Breweries of Canada, which beverage giant <b>Anheuser-Busch InBev&nbsp;</b>owns.</p>\n<p>According to Fortune Business Insights, the global cannabis beverage market is one of the hottest growth sectors right now. Analysts expect the market to grow at a compound annual growth rate of 50.9% until 2027, when it will become worth more than $8.5 billion. So it's a significant opportunity for the sector, and one that Tilray clearly wants to cash in on.</p>\n<h2>More acquisitions could be on the way</h2>\n<p>Growth is the focus for Tilray as it announced a goal of hitting $4 billion in annual revenue by 2024. However, the&nbsp;company is not even at an annual run rate of $1 billion, so it has quite a way to go. That's a big reason why I expect many more acquisitions on the horizon for the company in the next few years.</p>\n<p>While that will grow its top line, the danger for investors is that it could also mean more dilution. This recent acquisition of Breckenridge cost the company $102.9 million, funded entirely through shares. And Tilray has burned through $82 million in cash from its day-to-day operations over the past four quarters. Not only does it need to raise cash for these acquisitions, but it also needs to do so just to maintain its current operations.</p>\n<h2>Does this acquisition make Tilray a better buy?</h2>\n<p>Tilray is in a risky spot right now because it has put all its cards on the table, aiming for $4 billion in revenue in just a few years. In a rising interest rate environment where it could soon become more costly to raise debt, there could be lots of dilution on the way for investors as management may resort to raising equity capital.</p>\n<p>Its shares have already crumbled 58% in the past six months (the&nbsp;<b>Horizons Marijuana Life Sciences ETF</b> is down 41% during this time), and issuing more stock will only make things worse for investors. Moreover, acquisitions come with complexity that could create challenges. And given that more are likely on the way for Tilray, investors should tread carefully with this pot stock as things could worsen before they get better.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Makes Another Key Acquisition in the U.S.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Makes Another Key Acquisition in the U.S.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 19:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/16/tilray-makes-another-key-acquisition-in-the-us/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cannabis producer Tilray (NASDAQ:TLRY) is among many Canadian businesses jockeying for position in the U.S. pot market, even though it isn't open just yet. One of the ways it can penetrate the market ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/16/tilray-makes-another-key-acquisition-in-the-us/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4547":"WSB热门概念","BK4007":"制药","TLRY":"Tilray Inc.","BK4557":"大麻股"},"source_url":"https://www.fool.com/investing/2021/12/16/tilray-makes-another-key-acquisition-in-the-us/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191910863","content_text":"Cannabis producer Tilray (NASDAQ:TLRY) is among many Canadian businesses jockeying for position in the U.S. pot market, even though it isn't open just yet. One of the ways it can penetrate the market is through beverage companies that aren't currently selling cannabis-related products but could be leveraged to help enter the lucrative cannabis beverage market in the future. Plus, it gives the business a way to diversify its operations outside of marijuana.\nAnd that's what Tilray has done with yet another acquisition in the U.S. But will all this wheeling and dealing pay off, or could it lead to more challenges ahead for the business?\nAcquisition of Breckenridge Distillery will open up more opportunities and add to Tilray's bottom line\nOn Dec. 8, Tilray announced that it would be acquiring Colorado-based Breckenridge Distillery, which it says is \"widely known for its award-winning bourbon whiskey collection and innovative craft spirits portfolio.\" There are two key aspects of note in the deal: First, the deal will be immediately accretive to the company's earnings before interest, taxes, depreciation and amortization (EBITDA), meaning Breckenridge's profits will reflect on Tilray's financial reporting as soon as the next quarter.\nSecond, when it's legal to do so (i.e., when the U.S. legalizes marijuana at the federal level), it will allow Tilray to develop new products, including cannabis-infused whiskey.\nWhile the new opportunities are great, communicating profitability (on an adjusted EBITDA basis) is also essential. When the company released its first-quarter numbers for its fiscal 2022 in October, it marked the 10th consecutive period where Tilray posted an adjusted EBITDA profit, which is a streak it certainly doesn't want to interrupt. Moreover, maintaining a profit is one way Tilray can differentiate itself from other cannabis companies, many of which struggle with breaking even.\nThe move complements a broader strategy for Tilray\nThe beverage industry isn't a new target for Tilray. In Q1, it reported $15.5 million in revenue from alcoholic beverages from the SweetWater Brewing Company, which Aphria (which has since merged with Tilray) acquired last year. SweetWater is among the largest independent craft brewers in the U.S., and Tilray announced in November that it has entered the spirits category with the launch of two ready-to-drink cocktails. Tilray's interest in the cannabis beverage market goes back to 2018, when it announced a research partnership with Labatt Breweries of Canada, which beverage giant Anheuser-Busch InBev owns.\nAccording to Fortune Business Insights, the global cannabis beverage market is one of the hottest growth sectors right now. Analysts expect the market to grow at a compound annual growth rate of 50.9% until 2027, when it will become worth more than $8.5 billion. So it's a significant opportunity for the sector, and one that Tilray clearly wants to cash in on.\nMore acquisitions could be on the way\nGrowth is the focus for Tilray as it announced a goal of hitting $4 billion in annual revenue by 2024. However, the company is not even at an annual run rate of $1 billion, so it has quite a way to go. That's a big reason why I expect many more acquisitions on the horizon for the company in the next few years.\nWhile that will grow its top line, the danger for investors is that it could also mean more dilution. This recent acquisition of Breckenridge cost the company $102.9 million, funded entirely through shares. And Tilray has burned through $82 million in cash from its day-to-day operations over the past four quarters. Not only does it need to raise cash for these acquisitions, but it also needs to do so just to maintain its current operations.\nDoes this acquisition make Tilray a better buy?\nTilray is in a risky spot right now because it has put all its cards on the table, aiming for $4 billion in revenue in just a few years. In a rising interest rate environment where it could soon become more costly to raise debt, there could be lots of dilution on the way for investors as management may resort to raising equity capital.\nIts shares have already crumbled 58% in the past six months (the Horizons Marijuana Life Sciences ETF is down 41% during this time), and issuing more stock will only make things worse for investors. Moreover, acquisitions come with complexity that could create challenges. And given that more are likely on the way for Tilray, investors should tread carefully with this pot stock as things could worsen before they get better.","news_type":1,"symbols_score_info":{"TLRY":0.9}},"isVote":1,"tweetType":1,"viewCount":1600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607553550,"gmtCreate":1639568276415,"gmtModify":1639568277039,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607553550","repostId":"2191074962","repostType":4,"repost":{"id":"2191074962","kind":"highlight","pubTimestamp":1639567600,"share":"https://ttm.financial/m/news/2191074962?lang=&edition=full","pubTime":"2021-12-15 19:26","market":"us","language":"en","title":"1 Unstoppable Vanguard ETF That Could Double Your Money in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2191074962","media":"Motley Fool","summary":"Over time, you could earn hundreds of thousands of dollars or more with this ETF.","content":"<p>The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new year off with a bang.</p>\n<p>With countless stocks and funds to choose from, though, it can sometimes be overwhelming to pick the right <a href=\"https://laohu8.com/S/AONE.U\">one</a>.</p>\n<p>There's one exchange-traded fund (ETF), however, that's lower-risk and also packs a punch: the <b>Vanguard S&amp;P 500 ETF</b> (NYSEMKT:VOO). Not only does this ETF make a smart long-term investment, but by investing now, you could also potentially double your money in 2022.</p>\n<h2>Why invest in an S&amp;P 500 ETF?</h2>\n<p>The Vanguard S&amp;P 500 ETF aims to mirror the performance of the <b>S&amp;P 500</b> index itself. It contains stocks from the same 500 companies, and it's designed to earn roughly the same returns as the index.</p>\n<p>This ETF has several advantages, too. For one, it's very likely to survive stock market turbulence. The S&amp;P 500 itself does experience short-term volatility, but it's always recovered from every downturn it's ever faced.</p>\n<p>Nobody knows for certain if a market crash is looming, but some experts believe we'll see a downturn in 2022. If that happens, an S&amp;P 500 ETF can be a smart investment to have in your portfolio. Although it may take a hit in the short term, it's almost guaranteed to bounce back eventually.</p>\n<p>The Vanguard S&amp;P 500 ETF is also a powerhouse investment that can help your savings grow relatively quickly. Historically, the S&amp;P 500 has earned an average annual return of around 10% per year. Some years you may earn less than that, while other years (such as 2020 and 2021), you could earn significantly higher returns.</p>\n<h2>How to double your money in 2022</h2>\n<p>When investing in the stock market, time is your most valuable resource. One of the best ways to increase your savings is to invest consistently and give your money as much time as possible to grow.</p>\n<p>Say you invest $1,000 in the Vanguard S&amp;P 500 ETF on January 1, 2022. Let's also say you continue investing $100 per month, and you're earning a 10% average annual rate of return. By the end of the year, you'll have a total of around $2,300.</p>\n<p>Of course, nothing is guaranteed when it comes to the stock market. If 2022 is a rough year for the market, you may earn lower returns. Over the long run, though, you're likely to see positive returns and accumulate a substantial amount of money as long as you continue investing regularly.</p>\n<p>For instance, say that you continue investing $100 per month in the Vanguard S&amp;P 500 ETF. After 10 years, you'll have close to $28,000, assuming you're still earning a 10% average annual return. In 30 years, you'll have accumulated around $215,000.</p>\n<p>Investing in the stock market can be a fantastic way to generate wealth, and the Vanguard S&amp;P 500 ETF is a strong choice for many reasons. Regardless of where you invest, getting started now and investing consistently can make it easier to make money in the stock market.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Unstoppable Vanguard ETF That Could Double Your Money in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Unstoppable Vanguard ETF That Could Double Your Money in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 19:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/15/1-unstoppable-vanguard-etf-double-your-money-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/15/1-unstoppable-vanguard-etf-double-your-money-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","IVV":"标普500指数ETF","BK4559":"巴菲特持仓","BK4504":"桥水持仓","SPXU":"三倍做空标普500ETF","SPY":"标普500ETF","BK4550":"红杉资本持仓",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","BK4534":"瑞士信贷持仓","SH":"标普500反向ETF","OEF":"标普100指数ETF-iShares","OEX":"标普100"},"source_url":"https://www.fool.com/investing/2021/12/15/1-unstoppable-vanguard-etf-double-your-money-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191074962","content_text":"The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new year off with a bang.\nWith countless stocks and funds to choose from, though, it can sometimes be overwhelming to pick the right one.\nThere's one exchange-traded fund (ETF), however, that's lower-risk and also packs a punch: the Vanguard S&P 500 ETF (NYSEMKT:VOO). Not only does this ETF make a smart long-term investment, but by investing now, you could also potentially double your money in 2022.\nWhy invest in an S&P 500 ETF?\nThe Vanguard S&P 500 ETF aims to mirror the performance of the S&P 500 index itself. It contains stocks from the same 500 companies, and it's designed to earn roughly the same returns as the index.\nThis ETF has several advantages, too. For one, it's very likely to survive stock market turbulence. The S&P 500 itself does experience short-term volatility, but it's always recovered from every downturn it's ever faced.\nNobody knows for certain if a market crash is looming, but some experts believe we'll see a downturn in 2022. If that happens, an S&P 500 ETF can be a smart investment to have in your portfolio. Although it may take a hit in the short term, it's almost guaranteed to bounce back eventually.\nThe Vanguard S&P 500 ETF is also a powerhouse investment that can help your savings grow relatively quickly. Historically, the S&P 500 has earned an average annual return of around 10% per year. Some years you may earn less than that, while other years (such as 2020 and 2021), you could earn significantly higher returns.\nHow to double your money in 2022\nWhen investing in the stock market, time is your most valuable resource. One of the best ways to increase your savings is to invest consistently and give your money as much time as possible to grow.\nSay you invest $1,000 in the Vanguard S&P 500 ETF on January 1, 2022. Let's also say you continue investing $100 per month, and you're earning a 10% average annual rate of return. By the end of the year, you'll have a total of around $2,300.\nOf course, nothing is guaranteed when it comes to the stock market. If 2022 is a rough year for the market, you may earn lower returns. Over the long run, though, you're likely to see positive returns and accumulate a substantial amount of money as long as you continue investing regularly.\nFor instance, say that you continue investing $100 per month in the Vanguard S&P 500 ETF. After 10 years, you'll have close to $28,000, assuming you're still earning a 10% average annual return. In 30 years, you'll have accumulated around $215,000.\nInvesting in the stock market can be a fantastic way to generate wealth, and the Vanguard S&P 500 ETF is a strong choice for many reasons. Regardless of where you invest, getting started now and investing consistently can make it easier to make money in the stock market.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,".SPX":0.9,"ETF":0.9,"ESmain":0.9,"IVV":0.9,"OEF":0.9,"OEX":0.9,"SDS":0.9,"SH":0.9,"SPXU":0.9,"SPY":0.9,"SSO":0.9,"UPRO":0.9}},"isVote":1,"tweetType":1,"viewCount":2845,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607397508,"gmtCreate":1639486342125,"gmtModify":1639486342312,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/607397508","repostId":"2191937005","repostType":4,"repost":{"id":"2191937005","kind":"highlight","pubTimestamp":1639485464,"share":"https://ttm.financial/m/news/2191937005?lang=&edition=full","pubTime":"2021-12-14 20:37","market":"us","language":"en","title":"Got $1,500? 3 Growth Stocks to Buy That Could Double Your Money","url":"https://stock-news.laohu8.com/highlight/detail?id=2191937005","media":"Motley Fool","summary":"Investing is a long-term game in which growth stocks are the best option.","content":"<p>To double your investment with marijuana stocks, <a href=\"https://laohu8.com/S/AONE.U\">one</a> needs a strong appetite for risk and lots of patience. The industry is still in its nascent stage and sees ups and downs, and the drug is still illegal federally in the U.S. But even with a limited legal market, these three cannabis multi-state operators (MSO) are performing exceptionally well.</p>\n<p>New York-based&nbsp;<b>Columbia Care</b>&nbsp;(OTC:CCHWF), Colorado-based&nbsp;<b>GrowGeneration</b>&nbsp;(NASDAQ:GRWG), and Illinois-based <b>Cresco Labs</b>&nbsp;(OTC:CRLBF) are smaller in size but have the potential to shine as the industry expands. If you have $1,500 spare money left after paying all your bills, let me tell you why these three growth stocks are your best bet to invest in now and grow your money in the long run.</p>\n<h2>1. Columbia Care</h2>\n<p>Even with a market cap of just $1.1 billion, this marijuana company is preparing itself to give tough competition to the bigger MSOs. Columbia Care operates 131 facilities, out of which 99 are retail stores. The company has grown itself with smart acquisitions. It recently acquired Colorado-based Medicine Man, and in June it completed its buyout of Green Leaf Medical, strengthening its positions in Colorado and the Mid-Atlantic.</p>\n<p>Although these acquisitions are burdening its short-term cost structure, they will bring in profits in the coming years. Columbia Care also targets limited license markets that are careful of how many licenses they issue. This helps the company garner a loyal customer base for its brands.</p>\n<p>These strategies led to another great quarter, with revenue surging 144% year over year to $132 million in the third quarter of 2021. It also recorded an outstanding jump of 634% in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $31 million from Q3 2020.&nbsp;During the same period ended Sept. 30, it also grew its gross profit margin to 49% from 39% a year ago.&nbsp;Besides the bigger markets of California and Colorado, limited license markets like Massachusetts, Ohio, Pennsylvania, Illinois, Maryland, and Virginia also contributed to the&nbsp;performance.&nbsp;</p>\n<p>Columbia Care's management expects some recent headwinds (delays in the opening of dispensaries and in the implementation of recreational markets in the states that recently legalized it) to affect full-year results. The revised guidance now includes revenue to come in the range of $470 million to $485 million, adjusted EBITDA in the range of $85 million to $95 million, and adjusted gross profit margin to be around 46% for 2021. </p>\n<p>The company isn't profitable yet, but with wise acquisition strategies and expansion plans, it won't be too long until it starts earning profits.</p>\n<h2>2. GrowGeneration</h2>\n<p>GrowGeneration is not a pure-play cannabis company but a pick-and-shovel cannabis company. This hydroponics supplier sells products and equipment used by marijuana growers. With a market cap of just $977 million, the company has a wide network of 62 stores nationally and has managed to grow its revenue and profits by an outstanding amount. In the first nine months of 2021, its revenue has surged to $331 million compared with $131 million in the same period a year ago. Net profits have also increased to $16.8 million from $3.8 million for the nine months ended Sept. 30, 2020. The company expects to further add $15 million in revenue annually from its recent acquisition of Washington-based Hoagtech Hydroponics. </p>\n<p>Projecting the same headwinds as Columbia Care, GrowGeneration also revised its 2021 guidance. It now expects full-year 2021 revenue to come in the range of $435 million to $440 million and adjusted EBITDA guidance to be in a range of $41 million to $43 million. It also&nbsp;plans to open 15 to 20 more stores next&nbsp;year. Management believes these headwinds will sort out by the second half of 2022.&nbsp; If the company manages to hit the upper end of the guidance, that will be a 128% increase from its 2020 revenue -- impressive growth for a small company.&nbsp;</p>\n<h2>3. Cresco Labs</h2>\n<p>This pure-play cannabis grower doesn't have a vast presence yet, but with just 40 stores, it is making a mark in the domestic markets. In its recent third quarter of 2021, ended Sept. 30, total revenue surged 41% year over year to $215 million. </p>\n<p>Cresco also follows the same strategy of targeting limited license markets like Pennsylvania, Illinois, and Ohio. This strategy has also benefited Cresco, helping it build a loyal customer base for its popular brands like Mindy's Edibles, High Supply, and more that brought in $106.2 million in retail revenue in Q3 (the rest came in from wholesale revenue). </p>\n<p>It has mostly taken advantage of the new recreational market in Illinois that has brought in huge sales since the state legalized it in January 2020. As of November, the state had already broken its record last year of $1 billion in recreational cannabis sales. </p>\n<p>The company recorded adjusted EBITDA of $56 million, compared with $40 million in the year-ago quarter. A net loss of $263,000 in Q3 came in as a disappointment, compared with a net profit of $25 million in Q3 2020, due to a noncash impairment charge of around $290 million. </p>\n<p>Management stated that this charge was related to the company's \"exit from third-party distribution agreements in California.\" But the good news is despite a net loss, Cresco reaffirmed its 2021 guidance. It still expects revenue to come in the range of $235 million to $245 million, adjusted EBITDA margin of 30% for 2021, and a gross profit margin above 50% for the rest of 2021.&nbsp;</p>\n<p>Do not be disheartened by the recent downfall of marijuana stocks. I believe this presents a lucrative opportunity as growth stocks take time to show their full potential. As the burgeoning and recession-resistant cannabis industry expands, so will these three companies. Analysts see upsides of 126%, 210%, and 106% for GrowGeneration, Columbia Care, and Cresco Labs' stock, respectively,&nbsp;in the next 12 months. All three pot stocks are trading below their 52-week highs, making it the right time to put in your money.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,500? 3 Growth Stocks to Buy That Could Double Your Money</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,500? 3 Growth Stocks to Buy That Could Double Your Money\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 20:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/got-1500-3-growth-stocks-to-buy-that-could-double/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To double your investment with marijuana stocks, one needs a strong appetite for risk and lots of patience. The industry is still in its nascent stage and sees ups and downs, and the drug is still ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/got-1500-3-growth-stocks-to-buy-that-could-double/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRWG":"GrowGeneration Corp.","BK4083":"家庭装潢零售","BK4557":"大麻股"},"source_url":"https://www.fool.com/investing/2021/12/14/got-1500-3-growth-stocks-to-buy-that-could-double/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191937005","content_text":"To double your investment with marijuana stocks, one needs a strong appetite for risk and lots of patience. The industry is still in its nascent stage and sees ups and downs, and the drug is still illegal federally in the U.S. But even with a limited legal market, these three cannabis multi-state operators (MSO) are performing exceptionally well.\nNew York-based Columbia Care (OTC:CCHWF), Colorado-based GrowGeneration (NASDAQ:GRWG), and Illinois-based Cresco Labs (OTC:CRLBF) are smaller in size but have the potential to shine as the industry expands. If you have $1,500 spare money left after paying all your bills, let me tell you why these three growth stocks are your best bet to invest in now and grow your money in the long run.\n1. Columbia Care\nEven with a market cap of just $1.1 billion, this marijuana company is preparing itself to give tough competition to the bigger MSOs. Columbia Care operates 131 facilities, out of which 99 are retail stores. The company has grown itself with smart acquisitions. It recently acquired Colorado-based Medicine Man, and in June it completed its buyout of Green Leaf Medical, strengthening its positions in Colorado and the Mid-Atlantic.\nAlthough these acquisitions are burdening its short-term cost structure, they will bring in profits in the coming years. Columbia Care also targets limited license markets that are careful of how many licenses they issue. This helps the company garner a loyal customer base for its brands.\nThese strategies led to another great quarter, with revenue surging 144% year over year to $132 million in the third quarter of 2021. It also recorded an outstanding jump of 634% in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $31 million from Q3 2020. During the same period ended Sept. 30, it also grew its gross profit margin to 49% from 39% a year ago. Besides the bigger markets of California and Colorado, limited license markets like Massachusetts, Ohio, Pennsylvania, Illinois, Maryland, and Virginia also contributed to the performance. \nColumbia Care's management expects some recent headwinds (delays in the opening of dispensaries and in the implementation of recreational markets in the states that recently legalized it) to affect full-year results. The revised guidance now includes revenue to come in the range of $470 million to $485 million, adjusted EBITDA in the range of $85 million to $95 million, and adjusted gross profit margin to be around 46% for 2021. \nThe company isn't profitable yet, but with wise acquisition strategies and expansion plans, it won't be too long until it starts earning profits.\n2. GrowGeneration\nGrowGeneration is not a pure-play cannabis company but a pick-and-shovel cannabis company. This hydroponics supplier sells products and equipment used by marijuana growers. With a market cap of just $977 million, the company has a wide network of 62 stores nationally and has managed to grow its revenue and profits by an outstanding amount. In the first nine months of 2021, its revenue has surged to $331 million compared with $131 million in the same period a year ago. Net profits have also increased to $16.8 million from $3.8 million for the nine months ended Sept. 30, 2020. The company expects to further add $15 million in revenue annually from its recent acquisition of Washington-based Hoagtech Hydroponics. \nProjecting the same headwinds as Columbia Care, GrowGeneration also revised its 2021 guidance. It now expects full-year 2021 revenue to come in the range of $435 million to $440 million and adjusted EBITDA guidance to be in a range of $41 million to $43 million. It also plans to open 15 to 20 more stores next year. Management believes these headwinds will sort out by the second half of 2022.  If the company manages to hit the upper end of the guidance, that will be a 128% increase from its 2020 revenue -- impressive growth for a small company. \n3. Cresco Labs\nThis pure-play cannabis grower doesn't have a vast presence yet, but with just 40 stores, it is making a mark in the domestic markets. In its recent third quarter of 2021, ended Sept. 30, total revenue surged 41% year over year to $215 million. \nCresco also follows the same strategy of targeting limited license markets like Pennsylvania, Illinois, and Ohio. This strategy has also benefited Cresco, helping it build a loyal customer base for its popular brands like Mindy's Edibles, High Supply, and more that brought in $106.2 million in retail revenue in Q3 (the rest came in from wholesale revenue). \nIt has mostly taken advantage of the new recreational market in Illinois that has brought in huge sales since the state legalized it in January 2020. As of November, the state had already broken its record last year of $1 billion in recreational cannabis sales. \nThe company recorded adjusted EBITDA of $56 million, compared with $40 million in the year-ago quarter. A net loss of $263,000 in Q3 came in as a disappointment, compared with a net profit of $25 million in Q3 2020, due to a noncash impairment charge of around $290 million. \nManagement stated that this charge was related to the company's \"exit from third-party distribution agreements in California.\" But the good news is despite a net loss, Cresco reaffirmed its 2021 guidance. It still expects revenue to come in the range of $235 million to $245 million, adjusted EBITDA margin of 30% for 2021, and a gross profit margin above 50% for the rest of 2021. \nDo not be disheartened by the recent downfall of marijuana stocks. I believe this presents a lucrative opportunity as growth stocks take time to show their full potential. As the burgeoning and recession-resistant cannabis industry expands, so will these three companies. Analysts see upsides of 126%, 210%, and 106% for GrowGeneration, Columbia Care, and Cresco Labs' stock, respectively, in the next 12 months. All three pot stocks are trading below their 52-week highs, making it the right time to put in your money.","news_type":1,"symbols_score_info":{"GRWG":0.9,"MSO":0.9}},"isVote":1,"tweetType":1,"viewCount":2181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604216445,"gmtCreate":1639401867647,"gmtModify":1639401868247,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604216445","repostId":"1161576842","repostType":4,"repost":{"id":"1161576842","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639400492,"share":"https://ttm.financial/m/news/1161576842?lang=&edition=full","pubTime":"2021-12-13 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1161576842","media":"Tiger Newspress","summary":"U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-ba","content":"<p>U.S.&nbsp;stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p>\n<p>At 8:00 a.m. ET, S&amp;P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.<img src=\"https://static.tigerbbs.com/2db870f3d308c4d0618dd8c4333e65dd\" tg-width=\"1080\" tg-height=\"383\" referrerpolicy=\"no-referrer\">The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p>\n<p>Fed Chair Jerome Powell, as well as&nbsp;a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p>\n<p>“We believe markets can continue to&nbsp;take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p>\n<p>As of Sunday, the&nbsp;U.S. was approaching&nbsp;800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/HOG\">Harley-Davidson</a></b>– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”</p>\n<p><b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> rose 1.4% in the premarket while <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> jumped 4.4% after&nbsp;a new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.</p>\n<p><b><a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals</a> </b>– The drugmaker&nbsp;agreed to be acquired by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&nbsp;for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.</p>\n<p><b><a href=\"https://laohu8.com/S/PTON\">Peloton Interactive, Inc.</a></b> – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad&nbsp;featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.</p>\n<p><b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> </b>– The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.</p>\n<p><b><a href=\"https://laohu8.com/S/AAPL\">Apple</a> </b>– <a href=\"https://laohu8.com/S/AAPL\">Apple</a> rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.</p>\n<p>Nasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include&nbsp;<b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b>, up 2.7%;<b><a href=\"https://laohu8.com/S/ABNB\">Airbnb, Inc.</a></b> , up 2.1%;<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b> , up 3.7%;<b><a href=\"https://laohu8.com/S/LCID\">Lucid Group Inc</a></b>, up 5.9%;<b><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a></b>, up 3.4%; and&nbsp;<b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>, up 3.1%.</p>\n<p>Nasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include&nbsp;<b><a href=\"https://laohu8.com/S/CDW\">CDW Corp</a></b> , down 1.8% in the premarket;<b><a href=\"https://laohu8.com/S/FOXA\">Fox Corporation Class A</a></b> , down 2.2%;<b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> , down 1.8%;<b><a href=\"https://laohu8.com/S/CHKP\">Check Point</a></b> , down 1.1%;<b><a href=\"https://laohu8.com/S/TCOM\">Trip.com Group Limited</a></b> , down 1.2%; and&nbsp;<b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>, down 0.6%.</p>\n<p><b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named&nbsp;Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.&nbsp;stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p>\n<p>At 8:00 a.m. ET, S&amp;P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.<img src=\"https://static.tigerbbs.com/2db870f3d308c4d0618dd8c4333e65dd\" tg-width=\"1080\" tg-height=\"383\" referrerpolicy=\"no-referrer\">The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.</p>\n<p>Fed Chair Jerome Powell, as well as&nbsp;a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.</p>\n<p>“We believe markets can continue to&nbsp;take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.</p>\n<p>As of Sunday, the&nbsp;U.S. was approaching&nbsp;800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/HOG\">Harley-Davidson</a></b>– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”</p>\n<p><b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> rose 1.4% in the premarket while <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> jumped 4.4% after&nbsp;a new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.</p>\n<p><b><a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals</a> </b>– The drugmaker&nbsp;agreed to be acquired by <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&nbsp;for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.</p>\n<p><b><a href=\"https://laohu8.com/S/PTON\">Peloton Interactive, Inc.</a></b> – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad&nbsp;featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.</p>\n<p><b><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> </b>– The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.</p>\n<p><b><a href=\"https://laohu8.com/S/AAPL\">Apple</a> </b>– <a href=\"https://laohu8.com/S/AAPL\">Apple</a> rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.</p>\n<p>Nasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include&nbsp;<b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b>, up 2.7%;<b><a href=\"https://laohu8.com/S/ABNB\">Airbnb, Inc.</a></b> , up 2.1%;<b><a href=\"https://laohu8.com/S/FTNT\">Fortinet</a></b> , up 3.7%;<b><a href=\"https://laohu8.com/S/LCID\">Lucid Group Inc</a></b>, up 5.9%;<b><a href=\"https://laohu8.com/S/ZS\">Zscaler Inc.</a></b>, up 3.4%; and&nbsp;<b><a href=\"https://laohu8.com/S/DDOG\">Datadog</a></b>, up 3.1%.</p>\n<p>Nasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include&nbsp;<b><a href=\"https://laohu8.com/S/CDW\">CDW Corp</a></b> , down 1.8% in the premarket;<b><a href=\"https://laohu8.com/S/FOXA\">Fox Corporation Class A</a></b> , down 2.2%;<b><a href=\"https://laohu8.com/S/CERN\">Cerner</a></b> , down 1.8%;<b><a href=\"https://laohu8.com/S/CHKP\">Check Point</a></b> , down 1.1%;<b><a href=\"https://laohu8.com/S/TCOM\">Trip.com Group Limited</a></b> , down 1.2%; and&nbsp;<b><a href=\"https://laohu8.com/S/INCY\">Incyte</a></b>, down 0.6%.</p>\n<p><b><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive, Inc.</a></b> – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named&nbsp;Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INCY":"因塞特医疗","PFE":"辉瑞","TCOM":"携程网","DDOG":"Datadog","ABNB":"爱彼迎","ZS":"Zscaler Inc.","HOG":"哈雷戴维森","CERN":"美国塞纳",".DJI":"道琼斯","FTNT":"飞塔信息","LCID":"Lucid Group Inc",".IXIC":"NASDAQ Composite","PANW":"Palo Alto Networks","AAPL":"苹果","PTON":"Peloton Interactive, Inc.","ARNA":"阿里那",".SPX":"S&P 500 Index","FOXA":"福克斯-A","RIVN":"Rivian Automotive, Inc.","BNTX":"BioNTech SE","CDW":"CDW Corporation","CHKP":"Check Point软件科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161576842","content_text":"U.S. stock-index futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.\nAt 8:00 a.m. ET, S&P 500 e-minis were up 11.25 points, or 0.24%, Nasdaq 100 e-minis were up 67 points, or 0.41%, and Dow e-minis were up 24 points, or 0.07%.The key inflation reading came ahead of the Federal Reserve’s two-day policy meeting this week where the policymakers are expected to discuss speeding up the end of its bond-buying program.\nFed Chair Jerome Powell, as well as a parade of Fed speakers, all recently suggested the central bank could end the $120 billion monthly bond purchase program sooner than the current timeline of June 2022.\n“We believe markets can continue to take a higher inflation reading in their stride, though additional volatility remains a risk. With Fed policy staying relatively accommodative, the backdrop for equities is still positive, and we favor winners from global growth,” said Mark Haefele, Chief Investment Officer of UBS Global Wealth Management.\nAs of Sunday, the U.S. was approaching 800,000 coronavirus-related deaths. The new variant has pushed some government officials to reinstate health restrictions to slow the spread.\nStocks making the biggest moves premarket: \nHarley-Davidson– The motorcycle maker’s stock surged 11.7% in the premarket after it announced that it is merging its “Livewire” electric motorcycle unit with a special purpose acquisition company. Livewire will have an enterprise value of about $1.8 billion and will trade on the New York Stock Exchange under the ticker symbol “LVW.”\nPfizer,BioNTech SE – Pfizer rose 1.4% in the premarket while BioNTech SE jumped 4.4% after a new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant. Pfizer’s pre-market gains were trimmed following news of its deal to acquire Arena Pharmaceuticals.\nArena Pharmaceuticals – The drugmaker agreed to be acquired by Pfizer for $100 per share in cash, or about $6.7 billion. Arena soared 93.1% in premarket trading following news of the transaction.\nPeloton Interactive, Inc. – The fitness equipment maker rebounded 2.6% in premarket action after falling 7% over the past three sessions. Pelotonreleased an ad featuring actor Chris Noth promoting the value of the company’s equipment, after his character’s death in the “Sex and the City” reboot following a Peloton ride.\nDollar Tree – The discount retailer’s stock fell 1% in premarket trading after activist investor Mantle Ridge announced its intention to try to replace the entire Dollar Tree board. Dollar Tree called the move “unwarrantedly aggressive” and said it had offered to explore a settlement with Mantle Ridge, which owns 5.7% of Dollar Tree.\nApple – Apple rose 1.1% in the premarket after J.P. Morgan Securities raised its price target for the stock to a Street-high of $210 per share from $180 a share, and reiterated it as a top pick going into 2022.\nNasdaq-100 additions – Stocks being added to the index as of Monday, December 20, rose in premarket trading following news of their inclusion. The stocks include Palo Alto Networks, up 2.7%;Airbnb, Inc. , up 2.1%;Fortinet , up 3.7%;Lucid Group Inc, up 5.9%;Zscaler Inc., up 3.4%; and Datadog, up 3.1%.\nNasdaq-100 subtractions – Stocks being replaced in the Nasdaq-100 include CDW Corp , down 1.8% in the premarket;Fox Corporation Class A , down 2.2%;Cerner , down 1.8%;Check Point , down 1.1%;Trip.com Group Limited , down 1.2%; and Incyte, down 0.6%.\nRivian Automotive, Inc. – The electric vehicle maker’s stock rose 1.9% in the premarket following news that its R1T had been named Motor Trend’s truck of the year, beating out entries from Ford, GM and Hyundai.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"ABNB":0.9,"ARNA":0.9,"BNTX":0.9,"CDW":0.9,"CERN":0.9,"CHKP":0.9,"DDOG":0.9,"FOXA":0.9,"FTNT":0.9,"HOG":0.9,"INCY":0.9,"LCID":0.9,"PANW":0.9,"PFE":0.9,"PTON":0.9,"RIVN":0.9,"TCOM":0.9,"ZS":0.9}},"isVote":1,"tweetType":1,"viewCount":1744,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604967985,"gmtCreate":1639314176306,"gmtModify":1639314176494,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604967985","repostId":"1103250344","repostType":4,"repost":{"id":"1103250344","kind":"news","pubTimestamp":1639280672,"share":"https://ttm.financial/m/news/1103250344?lang=&edition=full","pubTime":"2021-12-12 11:44","market":"hk","language":"en","title":"US IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1103250344","media":"renaissancecap...","summary":"The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to r","content":"<p>The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to raise $789 million.</p>\n<p>IoT solutions developer<b>Samsara</b>(IOT) plans to raise $753 million at an $11.6 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22.</p>\n<p>Wine brand<b>Fresh Vine Wine</b>(VINE) plans to raise $21 million at a $116 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico.</p>\n<p>Micro-cap satellite developer<b>Sidus Space</b>(SIDU) plans to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection. &nbsp;Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21.</p>\n<p><img src=\"https://static.tigerbbs.com/ead80e54642569e2b7b368c8d50dc265\" tg-width=\"1409\" tg-height=\"457\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: IoT solutions, wine, and satellites in a 3 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 11:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89474/US-IPO-Week-Ahead-IoT-solutions-wine-and-satellites-in-a-3-IPO-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to raise $789 million.\nIoT solutions developerSamsara(IOT) plans to raise $753 million at an $11.6 ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89474/US-IPO-Week-Ahead-IoT-solutions-wine-and-satellites-in-a-3-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","IOT":"Samsara, Inc.",".IXIC":"NASDAQ Composite","SIDU":"Sidus Space Inc.",".SPX":"S&P 500 Index"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89474/US-IPO-Week-Ahead-IoT-solutions-wine-and-satellites-in-a-3-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103250344","content_text":"The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to raise $789 million.\nIoT solutions developerSamsara(IOT) plans to raise $753 million at an $11.6 billion market cap. This \"internet-of-things\" company provides a cloud-based platform that connects the assets of businesses with physical operations, enhancing operational efficiency and asset and employee productivity. Fast growing but highly unprofitable, Samsara saw double-digit growth for customers with $100k+ ARR in the 9mo FY22.\nWine brandFresh Vine Wine(VINE) plans to raise $21 million at a $116 million market cap. This celebrity-founded company produces low carb, low calorie premium wines. Growing but highly unprofitable, Fresh Vine sells its wines through wholesale, retail, and DTC channels, and is able to conduct wholesale distribution in all 50 states and Puerto Rico.\nMicro-cap satellite developerSidus Space(SIDU) plans to raise $15 million at an $81 million market cap. This company provides commercial satellite services such as design, manufacture, launch, and data collection.  Sidus Space has generated space-related manufacturing revenues to date, but is highly unprofitable with negative gross margin in the 9mo21.","news_type":1,"symbols_score_info":{".DJI":0,".IXIC":0,".SPX":0,"IOT":0,"SIDU":0,"VINE":0}},"isVote":1,"tweetType":1,"viewCount":1437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602448668,"gmtCreate":1639061486053,"gmtModify":1639061565941,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602448668","repostId":"1163135799","repostType":4,"repost":{"id":"1163135799","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639061282,"share":"https://ttm.financial/m/news/1163135799?lang=&edition=full","pubTime":"2021-12-09 22:48","market":"us","language":"en","title":"EV stocks fell in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1163135799","media":"Tiger Newspress","summary":"EV stocks fell in morning trading.Tesla,Rivian,Xpeng Motors,Lucid,Fisker,Arrival,Nikola and Canoo fe","content":"<p>EV stocks fell in morning trading.Tesla,Rivian,Xpeng Motors,Lucid,Fisker,Arrival,Nikola and Canoo fell between 1% and 6%.Nio&nbsp;and&nbsp;Li Auto&nbsp;rose slightly.</p>\n<p><img src=\"https://static.tigerbbs.com/c8a11efe3cb20d414d7ebc7c3c40a7eb\" tg-width=\"399\" tg-height=\"719\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks fell in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks fell in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-09 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks fell in morning trading.Tesla,Rivian,Xpeng Motors,Lucid,Fisker,Arrival,Nikola and Canoo fell between 1% and 6%.Nio&nbsp;and&nbsp;Li Auto&nbsp;rose slightly.</p>\n<p><img src=\"https://static.tigerbbs.com/c8a11efe3cb20d414d7ebc7c3c40a7eb\" tg-width=\"399\" tg-height=\"719\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车","NIO":"蔚来","LCID":"Lucid Group Inc","RIVN":"Rivian Automotive, Inc.","WKHS":"Workhorse Group, Inc.","FSR":"菲斯克","TSLA":"特斯拉","XPEV":"小鹏汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163135799","content_text":"EV stocks fell in morning trading.Tesla,Rivian,Xpeng Motors,Lucid,Fisker,Arrival,Nikola and Canoo fell between 1% and 6%.Nio and Li Auto rose slightly.","news_type":1,"symbols_score_info":{"FFIE":0.9,"FSR":0.9,"GOEV":0.9,"LCID":0.9,"LI":0.9,"NIO":0.9,"NKLA":0.9,"RIDE":0.9,"RIVN":0.9,"TSLA":0.9,"WKHS":0.9,"XPEV":0.9}},"isVote":1,"tweetType":1,"viewCount":679,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602951611,"gmtCreate":1638962069129,"gmtModify":1638962069269,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602951611","repostId":"2189666976","repostType":4,"isVote":1,"tweetType":1,"viewCount":645,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608721906,"gmtCreate":1638793166238,"gmtModify":1638793167957,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608721906","repostId":"1179313612","repostType":4,"repost":{"id":"1179313612","kind":"news","pubTimestamp":1638745398,"share":"https://ttm.financial/m/news/1179313612?lang=&edition=full","pubTime":"2021-12-06 07:03","market":"us","language":"en","title":"Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1179313612","media":"Barrons","summary":"Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer rep","content":"<p>Meme stock darling <a href=\"https://laohu8.com/S/GME\">GameStop</a> headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. <a href=\"https://laohu8.com/S/AZO\">AutoZone</a>, Casey’s <a href=\"https://laohu8.com/S/BGC\">General</a> Stores, and <a href=\"https://laohu8.com/S/TOL\">Toll Brothers</a> report earnings on Tuesday, followed by <a href=\"https://laohu8.com/S/BF.A\">Brown-Forman</a> and <a href=\"https://laohu8.com/S/CPB\">Campbell Soup</a> on Wednesday. <a href=\"https://laohu8.com/S/AVGO\">Broadcom</a>, <a href=\"https://laohu8.com/S/COST\">Costco</a> Wholesale, and <a href=\"https://laohu8.com/S/HRL\">Hormel</a> Foods round things out on Thursday.</p>\n<p>On Monday, <a href=\"https://laohu8.com/S/UNP\">Union Pacific</a> will hold a conference call to discuss its climate action plan. <a href=\"https://laohu8.com/S/MCK\">McKesson</a> and <a href=\"https://laohu8.com/S/LUV\">Southwest Airlines</a> host their 2021 investor days on Wednesday, followed by <a href=\"https://laohu8.com/S/CVS\">CVS Health</a> and <a href=\"https://laohu8.com/S/TSN\">Tyson</a> Foods on Thursday.</p>\n<p>The Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.</p>\n<p>The Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.</p>\n<p><b>Monday 12/6</b></p>\n<p>Union Pacific holds a conference call to discuss its climate action plan.</p>\n<p><b>Tuesday 12/7</b></p>\n<p>AutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.</p>\n<p>The Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.</p>\n<p><b>Wednesday 12/8</b></p>\n<p>The BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.</p>\n<p><a href=\"https://laohu8.com/S/BF.B\">Brown-Forman</a>, Campbell Soup, and GameStop report earnings.</p>\n<p>McKesson and <a href=\"https://laohu8.com/S/OKSB\">Southwest</a> Airlines host their 2021 investor days.</p>\n<p><a href=\"https://laohu8.com/S/EW\">Edwards Lifesciences</a> holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.</p>\n<p>The Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.</p>\n<p><b>Thursday 12/9</b></p>\n<p>Broadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.</p>\n<p>CVS Health and Tyson Foods host their annual investor days.</p>\n<p>The Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.</p>\n<p><b>Friday 12/10</b></p>\n<p>Archer-Daniels-Midland holds its global investor day.</p>\n<p><a href=\"https://laohu8.com/S/CNC\">Centene</a> holds an investor meeting and will provide financial guidance for 2022.</p>\n<p>The Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> finally ditched “transitory” when discussing inflation before the Senate Banking Committee.</p>\n<p>The University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGame Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 07:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. AutoZone, Casey’s General Stores, and Toll ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","CVS":"西维斯健康","BK4088":"住宅建筑","TOL":"托尔兄弟","COST":"好市多"},"source_url":"https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1179313612","content_text":"Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. AutoZone, Casey’s General Stores, and Toll Brothers report earnings on Tuesday, followed by Brown-Forman and Campbell Soup on Wednesday. Broadcom, Costco Wholesale, and Hormel Foods round things out on Thursday.\nOn Monday, Union Pacific will hold a conference call to discuss its climate action plan. McKesson and Southwest Airlines host their 2021 investor days on Wednesday, followed by CVS Health and Tyson Foods on Thursday.\nThe Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.\nThe Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.\nMonday 12/6\nUnion Pacific holds a conference call to discuss its climate action plan.\nTuesday 12/7\nAutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.\nThe Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.\nWednesday 12/8\nThe BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.\nBrown-Forman, Campbell Soup, and GameStop report earnings.\nMcKesson and Southwest Airlines host their 2021 investor days.\nEdwards Lifesciences holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.\nThe Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.\nThursday 12/9\nBroadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.\nCVS Health and Tyson Foods host their annual investor days.\nThe Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.\nFriday 12/10\nArcher-Daniels-Midland holds its global investor day.\nCentene holds an investor meeting and will provide financial guidance for 2022.\nThe Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome Powell finally ditched “transitory” when discussing inflation before the Senate Banking Committee.\nThe University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.","news_type":1,"symbols_score_info":{"COST":0.9,"CVS":0.9,"GME":0.9,"TOL":0.9}},"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601231796,"gmtCreate":1638532952161,"gmtModify":1638532952277,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601231796","repostId":"1150593666","repostType":4,"repost":{"id":"1150593666","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638531957,"share":"https://ttm.financial/m/news/1150593666?lang=&edition=full","pubTime":"2021-12-03 19:45","market":"us","language":"en","title":"Fastly stock climbed nearly 5% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1150593666","media":"Tiger Newspress","summary":"Fastly stock climbed nearly 5% in premarket trading after Raymond James upgraded the company.\n\nRaymo","content":"<p>Fastly stock climbed nearly 5% in premarket trading&nbsp;after&nbsp;Raymond&nbsp;James&nbsp;upgraded&nbsp;the&nbsp;company.</p>\n<p><img src=\"https://static.tigerbbs.com/c22bad4591e0eb973fa99c489362a47d\" tg-width=\"851\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Raymond James</b>&nbsp;analyst Frank Louthan upgraded&nbsp;<b>Fastly Inc</b>&nbsp;to Outperform from Market Perform&nbsp;with a $42 price target, implying 15.2% upside.</p>\n<ul>\n <li>Louthan says that the shares are about two points off the 52-week low and 20% below the 50-day moving average, with a recent uptick in short interest.</li>\n <li>However, Raymond James' propriety tracking tool suggests another sequential uptick in traffic and that Fastly should beat the high end of its revenue outlook, Louthan adds.</li>\n <li>This is a \"recipe for near-term share price appreciation,\" says the analyst.</li>\n <li>Fastly operates a content delivery network (CDN), which enables entities to provide faster and more reliable online content.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fastly stock climbed nearly 5% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFastly stock climbed nearly 5% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 19:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Fastly stock climbed nearly 5% in premarket trading&nbsp;after&nbsp;Raymond&nbsp;James&nbsp;upgraded&nbsp;the&nbsp;company.</p>\n<p><img src=\"https://static.tigerbbs.com/c22bad4591e0eb973fa99c489362a47d\" tg-width=\"851\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Raymond James</b>&nbsp;analyst Frank Louthan upgraded&nbsp;<b>Fastly Inc</b>&nbsp;to Outperform from Market Perform&nbsp;with a $42 price target, implying 15.2% upside.</p>\n<ul>\n <li>Louthan says that the shares are about two points off the 52-week low and 20% below the 50-day moving average, with a recent uptick in short interest.</li>\n <li>However, Raymond James' propriety tracking tool suggests another sequential uptick in traffic and that Fastly should beat the high end of its revenue outlook, Louthan adds.</li>\n <li>This is a \"recipe for near-term share price appreciation,\" says the analyst.</li>\n <li>Fastly operates a content delivery network (CDN), which enables entities to provide faster and more reliable online content.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSLY":"Fastly, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150593666","content_text":"Fastly stock climbed nearly 5% in premarket trading after Raymond James upgraded the company.\n\nRaymond James analyst Frank Louthan upgraded Fastly Inc to Outperform from Market Perform with a $42 price target, implying 15.2% upside.\n\nLouthan says that the shares are about two points off the 52-week low and 20% below the 50-day moving average, with a recent uptick in short interest.\nHowever, Raymond James' propriety tracking tool suggests another sequential uptick in traffic and that Fastly should beat the high end of its revenue outlook, Louthan adds.\nThis is a \"recipe for near-term share price appreciation,\" says the analyst.\nFastly operates a content delivery network (CDN), which enables entities to provide faster and more reliable online content.","news_type":1,"symbols_score_info":{"FSLY":0.9}},"isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603920179,"gmtCreate":1638354224611,"gmtModify":1638354224839,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/603920179","repostId":"1101865893","repostType":4,"isVote":1,"tweetType":1,"viewCount":878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609840175,"gmtCreate":1638269437904,"gmtModify":1638269438013,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609840175","repostId":"2187586148","repostType":4,"repost":{"id":"2187586148","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638264468,"share":"https://ttm.financial/m/news/2187586148?lang=&edition=full","pubTime":"2021-11-30 17:27","market":"us","language":"en","title":"5 Stocks To Watch For November 30, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2187586148","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b>Hewlett Packard Enterprise Company</b>&nbsp;(NYSE:HPE) to report quarterly earnings at $0.48 per share on revenue of $7.38 billion after the closing bell. Hewlett Packard Enterprise shares fell 1.2% to $14.43 in premarket trading&nbsp;Tuesday.</li>\n <li><b>UnitedHealth Group Inc</b> (NYSE:UNH) said it sees FY21 adjusted earnings of $18.75 to $18.90 per share on revenue of approximately $287 billion. The company also expects FY22 adjusted EPS of $21.10-$21.60 and revenue of $317 billion to $320 billion. UnitedHealth shares fell 1% to $447.7 in premarket trading&nbsp;Tuesday.</li>\n <li>Analysts are expecting <b>salesforce.com, inc.</b>&nbsp;(NYSE:CRM) to have earned $0.92 per share on revenue of $6.80 billion for the latest quarter. The company will release earnings after the markets close. salesforce.com shares dropped 0.6% to $294.98 in premarket tradingTuesday.</li>\n</ul>\n<ul>\n <li>Chatham Asset Management offered to acquire <b>R. R. Donnelley &amp; Sons Company</b> (NYSE:RRD) for $10.25 per share in cash. R. R. Donnelley shares gained 0.5% to $10.27 in after-hours trading, following a 10% surge in regular trading Monday.</li>\n <li>Analysts expect <b>NetApp, Inc.</b>&nbsp;(NASDAQ:NTAP) to post quarterly earnings at $1.21 per share on revenue of $1.55 billion after the closing bell. NetApp shares rose 0.3% to $91.80 in after-hours trading&nbsp;Monday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 30, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 30, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-30 17:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b>Hewlett Packard Enterprise Company</b>&nbsp;(NYSE:HPE) to report quarterly earnings at $0.48 per share on revenue of $7.38 billion after the closing bell. Hewlett Packard Enterprise shares fell 1.2% to $14.43 in premarket trading&nbsp;Tuesday.</li>\n <li><b>UnitedHealth Group Inc</b> (NYSE:UNH) said it sees FY21 adjusted earnings of $18.75 to $18.90 per share on revenue of approximately $287 billion. The company also expects FY22 adjusted EPS of $21.10-$21.60 and revenue of $317 billion to $320 billion. UnitedHealth shares fell 1% to $447.7 in premarket trading&nbsp;Tuesday.</li>\n <li>Analysts are expecting <b>salesforce.com, inc.</b>&nbsp;(NYSE:CRM) to have earned $0.92 per share on revenue of $6.80 billion for the latest quarter. The company will release earnings after the markets close. salesforce.com shares dropped 0.6% to $294.98 in premarket tradingTuesday.</li>\n</ul>\n<ul>\n <li>Chatham Asset Management offered to acquire <b>R. R. Donnelley &amp; Sons Company</b> (NYSE:RRD) for $10.25 per share in cash. R. R. Donnelley shares gained 0.5% to $10.27 in after-hours trading, following a 10% surge in regular trading Monday.</li>\n <li>Analysts expect <b>NetApp, Inc.</b>&nbsp;(NASDAQ:NTAP) to post quarterly earnings at $1.21 per share on revenue of $1.55 billion after the closing bell. NetApp shares rose 0.3% to $91.80 in after-hours trading&nbsp;Monday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4567":"ESG概念","UNH":"联合健康","BK4087":"商业印刷","CRM":"赛富时","BK4154":"管理型保健护理","BK4505":"高瓴资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","NTAP":"美国网存","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4515":"5G概念","BK4548":"巴美列捷福持仓","BK4527":"明星科技股","RRD":"当纳利","BK4538":"云计算","HPE":"慧与科技","BK4528":"SaaS概念"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187586148","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Hewlett Packard Enterprise Company (NYSE:HPE) to report quarterly earnings at $0.48 per share on revenue of $7.38 billion after the closing bell. Hewlett Packard Enterprise shares fell 1.2% to $14.43 in premarket trading Tuesday.\nUnitedHealth Group Inc (NYSE:UNH) said it sees FY21 adjusted earnings of $18.75 to $18.90 per share on revenue of approximately $287 billion. The company also expects FY22 adjusted EPS of $21.10-$21.60 and revenue of $317 billion to $320 billion. UnitedHealth shares fell 1% to $447.7 in premarket trading Tuesday.\nAnalysts are expecting salesforce.com, inc. (NYSE:CRM) to have earned $0.92 per share on revenue of $6.80 billion for the latest quarter. The company will release earnings after the markets close. salesforce.com shares dropped 0.6% to $294.98 in premarket tradingTuesday.\n\n\nChatham Asset Management offered to acquire R. R. Donnelley & Sons Company (NYSE:RRD) for $10.25 per share in cash. R. R. Donnelley shares gained 0.5% to $10.27 in after-hours trading, following a 10% surge in regular trading Monday.\nAnalysts expect NetApp, Inc. (NASDAQ:NTAP) to post quarterly earnings at $1.21 per share on revenue of $1.55 billion after the closing bell. NetApp shares rose 0.3% to $91.80 in after-hours trading Monday.","news_type":1,"symbols_score_info":{"CRM":0.9,"HPE":0.9,"NTAP":0.9,"RRD":0.9,"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600545498,"gmtCreate":1638179392619,"gmtModify":1638180439436,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600545498","repostId":"1193304775","repostType":4,"repost":{"id":"1193304775","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638178459,"share":"https://ttm.financial/m/news/1193304775?lang=&edition=full","pubTime":"2021-11-29 17:34","market":"us","language":"en","title":"5 Stocks To Watch For November 29, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1193304775","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\nLi Auto's Q3 results beat estimates.its ","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Li Auto's Q3 results beat estimates.its&nbsp;total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects&nbsp;<b>Li Auto Inc.</b>&nbsp;to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading&nbsp;Monday.</li>\n <li><b>Moderna, Inc.</b>, which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.</li>\n <li>Analysts are expecting&nbsp;<b>StoneX Group Inc.</b>&nbsp;to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.</li>\n</ul>\n<ul>\n <li><b>Tesla, Inc</b>&nbsp;will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more&nbsp;than&nbsp;2% to $1,106.2 in premarket tradingMonday.</li>\n <li>Frontline's Q3 results missed estimates.Analysts expect&nbsp;<b>Frontline Ltd.</b>&nbsp;to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to&nbsp;$6.61 in premarket tradingMonday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 29, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 29, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-29 17:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Li Auto's Q3 results beat estimates.its&nbsp;total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects&nbsp;<b>Li Auto Inc.</b>&nbsp;to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading&nbsp;Monday.</li>\n <li><b>Moderna, Inc.</b>, which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.</li>\n <li>Analysts are expecting&nbsp;<b>StoneX Group Inc.</b>&nbsp;to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.</li>\n</ul>\n<ul>\n <li><b>Tesla, Inc</b>&nbsp;will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more&nbsp;than&nbsp;2% to $1,106.2 in premarket tradingMonday.</li>\n <li>Frontline's Q3 results missed estimates.Analysts expect&nbsp;<b>Frontline Ltd.</b>&nbsp;to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to&nbsp;$6.61 in premarket tradingMonday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","SNEX":"StoneX Group Inc.","LI":"理想汽车","MRNA":"Moderna, Inc.","FRO":"FRONTLINE PLC"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193304775","content_text":"Some of the stocks that may grab investor focus today are:\n\nLi Auto's Q3 results beat estimates.its total revenues reached $1.21 billion;deliveries reached 25,116 vehicles;gross margin reached 23.3%.Wall Street expects Li Auto Inc. to report a quarterly loss at $0.02 per share on revenue of $1.16 billion before the opening bell. Li Auto shares rose 5.8% to $34.29 in premarket trading Monday.\nModerna, Inc., which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat. The company’s current vaccine will be tested against the new variant, and its ability to offer immunity will likely be known over the next couple of weeks, the company's chief medical officer Paul Burton reportedly said on BBC's \"Andrew Marr Show.\" Moderna shares rose 10.2% to $363.3 in premarket tradingMonday.\nAnalysts are expecting StoneX Group Inc. to have earned $1.44 per share on revenue of $280.55 million for the latest quarter. The company will release earnings after the closing bell. StoneX shares dropped 3.4% to close at $66.70 on Friday.\n\n\nTesla, Inc will likely commence production operations at its Giga Berlin in Germany in December, Bloomberg reported, citing German magazine Automobilwoche. Tesla shares rallied more than 2% to $1,106.2 in premarket tradingMonday.\nFrontline's Q3 results missed estimates.Analysts expect Frontline Ltd. to post a quarterly loss at $1.58 per share on revenue of $605.57 million before the opening bell. Frontline shares dropped 2.8% to $6.61 in premarket tradingMonday.","news_type":1,"symbols_score_info":{"FRO":0.9,"LI":0.9,"MRNA":0.9,"SNEX":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877616164,"gmtCreate":1637923320995,"gmtModify":1637923321108,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877616164","repostId":"1164520709","repostType":4,"repost":{"id":"1164520709","kind":"news","pubTimestamp":1637922883,"share":"https://ttm.financial/m/news/1164520709?lang=&edition=full","pubTime":"2021-11-26 18:34","market":"us","language":"en","title":"All Eyes on U.S. Opening as Global Rout Spreads: Markets Wrap","url":"https://stock-news.laohu8.com/highlight/detail?id=1164520709","media":"Bloomberg","summary":"(Bloomberg) -- A post-Thanksgiving selloff spread across global markets from stocks to commodities, ","content":"<p>(Bloomberg) -- A post-Thanksgiving selloff spread across global markets from stocks to commodities, and haven assets rallied, amid fears a new coronavirus variant identified in South Africa could spark fresh outbreaks and scuttle a fragile economic recovery.</p>\n<p>All eyes were on the opening bell in the U.S. markets, set to return from the holiday for a shortened trading session. Futures signaled the rout that started in Asia and spread to Europe won’t spare New York equities. A surge in Treasuries suggested traders were cutting bets on monetary tightening by the Federal Reserve. The dollar missed a beat as a haven currency as the yen dominated that role.</p>\n<p>“Every trader in New York will be rushing to the office now,” said Frederik Hildner, a money manager at Salm-Salm &amp; Partner.</p>\n<p>Contracts on the S&amp;P 500 Index and the Dow Jones Industrial Average slumped the most since September. Russell 2000 contracts sank as much as 5.4%. Technology shares may also be caught in the net too as Nasdaq 100 futures fell 1.2%.</p>\n<p>The World Health Organization and scientists in South Africa were said to be working “at lightening speed” to ascertain how quickly the B.1.1.529 variant can spread and whether it’s resistant to vaccines. The new threat adds to the wall of worry investors are already contending with in the form of elevated inflation, monetary tightening and slowing growth.</p>\n<p>Global travel stocks were in particular focus after the European Union, U.K., Israel, and Singapore placed emergency curbs on passengers from South Africa and the surrounding region. British Airways parent IAG SA tumbled as much as 21% in London. Carnival Corp. and Royal Caribbean Cruises Ltd. lost 9% each in New York premarket session. Stay-at-home stocks such as Zoom Video Communications Inc. jumped in the early trading.</p>\n<p>Europe’s equity benchmark headed for the biggest drop this year. Ten-year Treasury yields shed 11 basis points while the Japanese yen jumped the most since investors’ March 2020 rush for safety. Crude oil to emerging markets completed this picture of mayhem.</p>\n<p>“Investors are worried about the growing possibility of a new series of lockdowns, which could curb the recovery,” Carlo Alberto De Casa, an external market analyst for Kinesis Money, wrote in emailed comments. “Central banks could be forced to review their strategies and exit plans from quantitative easing if the scenario is worsening again.”</p>\n<p>Traders rushed to cut back their bets on rate hikes. Money markets now price less than a 10-basis-point hike by the Bank of England next month, compared with 35 basis points projected less than a month ago. They expect seven basis points of tightening by the European Central Bank by December 2022 as against nine basis points seen Thursday.</p>\n<p>The yen and Swiss franc found bids from safety-conscious traders, while the dollar languished. A gain for the euro, the biggest component of the Bloomberg Dollar Spot Index, also curbed the greenback.</p>\n<p>MSCI Inc.’s Asia-Pacific equity gauge slid to the lowest since early October, with Japan and Hong Kong underperforming.</p>\n<p>Some of the worst-hit assets were in emerging markets. The currency of South Africa, where the virus strain was identified, sank 2.1% and the Mexican peso fell by a similar degree. The MSCI EM Currency Index fell to a six-week low.</p>\n<p>Crude oil futures in New York dropped as much as 7.4% to trade below $73 per barrel. Copper, nickel and aluminum each declined at least 2.9% in London trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>All Eyes on U.S. Opening as Global Rout Spreads: Markets Wrap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAll Eyes on U.S. Opening as Global Rout Spreads: Markets Wrap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-26 18:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/asian-stocks-set-mixed-open-220453170.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- A post-Thanksgiving selloff spread across global markets from stocks to commodities, and haven assets rallied, amid fears a new coronavirus variant identified in South Africa could ...</p>\n\n<a href=\"https://finance.yahoo.com/news/asian-stocks-set-mixed-open-220453170.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/asian-stocks-set-mixed-open-220453170.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164520709","content_text":"(Bloomberg) -- A post-Thanksgiving selloff spread across global markets from stocks to commodities, and haven assets rallied, amid fears a new coronavirus variant identified in South Africa could spark fresh outbreaks and scuttle a fragile economic recovery.\nAll eyes were on the opening bell in the U.S. markets, set to return from the holiday for a shortened trading session. Futures signaled the rout that started in Asia and spread to Europe won’t spare New York equities. A surge in Treasuries suggested traders were cutting bets on monetary tightening by the Federal Reserve. The dollar missed a beat as a haven currency as the yen dominated that role.\n“Every trader in New York will be rushing to the office now,” said Frederik Hildner, a money manager at Salm-Salm & Partner.\nContracts on the S&P 500 Index and the Dow Jones Industrial Average slumped the most since September. Russell 2000 contracts sank as much as 5.4%. Technology shares may also be caught in the net too as Nasdaq 100 futures fell 1.2%.\nThe World Health Organization and scientists in South Africa were said to be working “at lightening speed” to ascertain how quickly the B.1.1.529 variant can spread and whether it’s resistant to vaccines. The new threat adds to the wall of worry investors are already contending with in the form of elevated inflation, monetary tightening and slowing growth.\nGlobal travel stocks were in particular focus after the European Union, U.K., Israel, and Singapore placed emergency curbs on passengers from South Africa and the surrounding region. British Airways parent IAG SA tumbled as much as 21% in London. Carnival Corp. and Royal Caribbean Cruises Ltd. lost 9% each in New York premarket session. Stay-at-home stocks such as Zoom Video Communications Inc. jumped in the early trading.\nEurope’s equity benchmark headed for the biggest drop this year. Ten-year Treasury yields shed 11 basis points while the Japanese yen jumped the most since investors’ March 2020 rush for safety. Crude oil to emerging markets completed this picture of mayhem.\n“Investors are worried about the growing possibility of a new series of lockdowns, which could curb the recovery,” Carlo Alberto De Casa, an external market analyst for Kinesis Money, wrote in emailed comments. “Central banks could be forced to review their strategies and exit plans from quantitative easing if the scenario is worsening again.”\nTraders rushed to cut back their bets on rate hikes. Money markets now price less than a 10-basis-point hike by the Bank of England next month, compared with 35 basis points projected less than a month ago. They expect seven basis points of tightening by the European Central Bank by December 2022 as against nine basis points seen Thursday.\nThe yen and Swiss franc found bids from safety-conscious traders, while the dollar languished. A gain for the euro, the biggest component of the Bloomberg Dollar Spot Index, also curbed the greenback.\nMSCI Inc.’s Asia-Pacific equity gauge slid to the lowest since early October, with Japan and Hong Kong underperforming.\nSome of the worst-hit assets were in emerging markets. The currency of South Africa, where the virus strain was identified, sank 2.1% and the Mexican peso fell by a similar degree. The MSCI EM Currency Index fell to a six-week low.\nCrude oil futures in New York dropped as much as 7.4% to trade below $73 per barrel. Copper, nickel and aluminum each declined at least 2.9% in London trading.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":435,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874547233,"gmtCreate":1637805446647,"gmtModify":1637805446734,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874547233","repostId":"2186363038","repostType":4,"repost":{"id":"2186363038","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637794515,"share":"https://ttm.financial/m/news/2186363038?lang=&edition=full","pubTime":"2021-11-25 06:55","market":"us","language":"en","title":"Wall Street ends higher; Nvidia surge offsets Nordstrom, Gap slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2186363038","media":"Reuters","summary":"* Nordstrom, Gap tumble on weak earnings\n* Core PCE index rises in October\n* Real estate leads among","content":"<p>* Nordstrom, Gap tumble on weak earnings</p>\n<p>* Core PCE index rises in October</p>\n<p>* Real estate leads among S&amp;P 500 sectors</p>\n<p>* Indexes: Dow -0.03%, S&amp;P 500 +0.23%, Nasdaq +0.44%</p>\n<p>Nov 24 (Reuters) - Wall Street ended higher on Wednesday, lifted by gains in Nvidia and other tech stocks, while Gap and Nordstrom shares tumbled following weak quarterly reports.</p>\n<p>Nordstrom tumbled 29% and Gap slid 24%, after the two retailers reported weak quarterly results and warned of supply chain problems ahead of the crucial U.S. holiday shopping season.</p>\n<p>Nvidia rallied 2.9% as it bounced back from a selloff in Big Tech stocks early this week. The graphics chipmaker is now up about 150% in 2021.</p>\n<p>The S&amp;P 500 spent much of the session near flat before climbing just before the close.</p>\n<p>The S&amp;P 500 consumer discretionary sector index rose 0.2% after data showed U.S. consumer spending increased more than expected in October.</p>\n<p>The so-called core PCE price index, the Federal Reserve's preferred inflation measure, also accelerated in October.</p>\n<p>Various Federal Reserve policymakers said they would be open to speeding up elimination of their bond-buying program and move more quickly to raise interest rates if high inflation held, minutes of the U.S. central bank's last policy meeting showed.</p>\n<p>Other data showed weekly jobless claims fell and third-quarter GDP was revised higher, while a University of Michigan survey showed consumer sentiment improved in November.</p>\n<p>Coronavirus infections broke records in parts of Europe on Wednesday, with investors worried the continent was again the epicenter of a pandemic that has prompted new curbs on movement.</p>\n<p>So far this week, the Nasdaq is down about 1.3%, with investors worried that higher interest rates could hurt the valuations of tech and other growth stocks.</p>\n<p>\"Equities are under pressure from a combination of rising interest rates, more cautionary news on the earnings front, and also from COVID developments in Europe,\" said Greg Bassuk, chief executive at AXS Investments in Port Chester, New York.</p>\n<p>The U.S. stock market will be closed on Thursday for the Thanksgiving holiday, and it will have a shortened session on Friday.</p>\n<p>Real estate led among 11 S&amp;P 500 sector indexes with a gain of 1.3% for most of the session.</p>\n<p>The Dow Jones Industrial Average fell 0.03% to end at 35,804.38 points, while the S&amp;P 500 gained 0.23% to 4,701.46.</p>\n<p>The Nasdaq Composite climbed 0.44% to 15,845.23.</p>\n<p>Volume on U.S. exchanges was 8.9 billion shares, light compared to the 11 billion average over the last 20 trading days.</p>\n<p>Tesla Inc rose as much as 0.6%. In his latest of several recent share sales, CEO Elon Musk sold 934,091 shares of the electric vehicle maker worth $1.05 billion after exercising options to buy 2.15 million shares.</p>\n<p>PC makers HP Inc and Dell Technologies jumped 10% and 4.8%, respectively, after they logged a more than four-fold rise in quarterly profits amid increasing demand for personal computers.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.15-to-1 ratio; on Nasdaq, a 1.47-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 27 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 55 new highs and 234 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends higher; Nvidia surge offsets Nordstrom, Gap slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends higher; Nvidia surge offsets Nordstrom, Gap slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-25 06:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Nordstrom, Gap tumble on weak earnings</p>\n<p>* Core PCE index rises in October</p>\n<p>* Real estate leads among S&amp;P 500 sectors</p>\n<p>* Indexes: Dow -0.03%, S&amp;P 500 +0.23%, Nasdaq +0.44%</p>\n<p>Nov 24 (Reuters) - Wall Street ended higher on Wednesday, lifted by gains in Nvidia and other tech stocks, while Gap and Nordstrom shares tumbled following weak quarterly reports.</p>\n<p>Nordstrom tumbled 29% and Gap slid 24%, after the two retailers reported weak quarterly results and warned of supply chain problems ahead of the crucial U.S. holiday shopping season.</p>\n<p>Nvidia rallied 2.9% as it bounced back from a selloff in Big Tech stocks early this week. The graphics chipmaker is now up about 150% in 2021.</p>\n<p>The S&amp;P 500 spent much of the session near flat before climbing just before the close.</p>\n<p>The S&amp;P 500 consumer discretionary sector index rose 0.2% after data showed U.S. consumer spending increased more than expected in October.</p>\n<p>The so-called core PCE price index, the Federal Reserve's preferred inflation measure, also accelerated in October.</p>\n<p>Various Federal Reserve policymakers said they would be open to speeding up elimination of their bond-buying program and move more quickly to raise interest rates if high inflation held, minutes of the U.S. central bank's last policy meeting showed.</p>\n<p>Other data showed weekly jobless claims fell and third-quarter GDP was revised higher, while a University of Michigan survey showed consumer sentiment improved in November.</p>\n<p>Coronavirus infections broke records in parts of Europe on Wednesday, with investors worried the continent was again the epicenter of a pandemic that has prompted new curbs on movement.</p>\n<p>So far this week, the Nasdaq is down about 1.3%, with investors worried that higher interest rates could hurt the valuations of tech and other growth stocks.</p>\n<p>\"Equities are under pressure from a combination of rising interest rates, more cautionary news on the earnings front, and also from COVID developments in Europe,\" said Greg Bassuk, chief executive at AXS Investments in Port Chester, New York.</p>\n<p>The U.S. stock market will be closed on Thursday for the Thanksgiving holiday, and it will have a shortened session on Friday.</p>\n<p>Real estate led among 11 S&amp;P 500 sector indexes with a gain of 1.3% for most of the session.</p>\n<p>The Dow Jones Industrial Average fell 0.03% to end at 35,804.38 points, while the S&amp;P 500 gained 0.23% to 4,701.46.</p>\n<p>The Nasdaq Composite climbed 0.44% to 15,845.23.</p>\n<p>Volume on U.S. exchanges was 8.9 billion shares, light compared to the 11 billion average over the last 20 trading days.</p>\n<p>Tesla Inc rose as much as 0.6%. In his latest of several recent share sales, CEO Elon Musk sold 934,091 shares of the electric vehicle maker worth $1.05 billion after exercising options to buy 2.15 million shares.</p>\n<p>PC makers HP Inc and Dell Technologies jumped 10% and 4.8%, respectively, after they logged a more than four-fold rise in quarterly profits amid increasing demand for personal computers.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.15-to-1 ratio; on Nasdaq, a 1.47-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 27 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 55 new highs and 234 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JWN":"诺德斯特龙",".SPX":"S&P 500 Index","TSLA":"特斯拉",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","HPQ":"惠普","DELL":"戴尔","NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186363038","content_text":"* Nordstrom, Gap tumble on weak earnings\n* Core PCE index rises in October\n* Real estate leads among S&P 500 sectors\n* Indexes: Dow -0.03%, S&P 500 +0.23%, Nasdaq +0.44%\nNov 24 (Reuters) - Wall Street ended higher on Wednesday, lifted by gains in Nvidia and other tech stocks, while Gap and Nordstrom shares tumbled following weak quarterly reports.\nNordstrom tumbled 29% and Gap slid 24%, after the two retailers reported weak quarterly results and warned of supply chain problems ahead of the crucial U.S. holiday shopping season.\nNvidia rallied 2.9% as it bounced back from a selloff in Big Tech stocks early this week. The graphics chipmaker is now up about 150% in 2021.\nThe S&P 500 spent much of the session near flat before climbing just before the close.\nThe S&P 500 consumer discretionary sector index rose 0.2% after data showed U.S. consumer spending increased more than expected in October.\nThe so-called core PCE price index, the Federal Reserve's preferred inflation measure, also accelerated in October.\nVarious Federal Reserve policymakers said they would be open to speeding up elimination of their bond-buying program and move more quickly to raise interest rates if high inflation held, minutes of the U.S. central bank's last policy meeting showed.\nOther data showed weekly jobless claims fell and third-quarter GDP was revised higher, while a University of Michigan survey showed consumer sentiment improved in November.\nCoronavirus infections broke records in parts of Europe on Wednesday, with investors worried the continent was again the epicenter of a pandemic that has prompted new curbs on movement.\nSo far this week, the Nasdaq is down about 1.3%, with investors worried that higher interest rates could hurt the valuations of tech and other growth stocks.\n\"Equities are under pressure from a combination of rising interest rates, more cautionary news on the earnings front, and also from COVID developments in Europe,\" said Greg Bassuk, chief executive at AXS Investments in Port Chester, New York.\nThe U.S. stock market will be closed on Thursday for the Thanksgiving holiday, and it will have a shortened session on Friday.\nReal estate led among 11 S&P 500 sector indexes with a gain of 1.3% for most of the session.\nThe Dow Jones Industrial Average fell 0.03% to end at 35,804.38 points, while the S&P 500 gained 0.23% to 4,701.46.\nThe Nasdaq Composite climbed 0.44% to 15,845.23.\nVolume on U.S. exchanges was 8.9 billion shares, light compared to the 11 billion average over the last 20 trading days.\nTesla Inc rose as much as 0.6%. In his latest of several recent share sales, CEO Elon Musk sold 934,091 shares of the electric vehicle maker worth $1.05 billion after exercising options to buy 2.15 million shares.\nPC makers HP Inc and Dell Technologies jumped 10% and 4.8%, respectively, after they logged a more than four-fold rise in quarterly profits amid increasing demand for personal computers.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.15-to-1 ratio; on Nasdaq, a 1.47-to-1 ratio favored advancers.\nThe S&P 500 posted 27 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 55 new highs and 234 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"DELL":0.9,"GPS":0.9,"HPQ":0.9,"JWN":0.9,"NVDA":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":657,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874873844,"gmtCreate":1637763156381,"gmtModify":1637763159127,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874873844","repostId":"1167653292","repostType":4,"repost":{"id":"1167653292","kind":"news","pubTimestamp":1637762873,"share":"https://ttm.financial/m/news/1167653292?lang=&edition=full","pubTime":"2021-11-24 22:07","market":"us","language":"en","title":"FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1167653292","media":"Benzinga","summary":"Relief Therapeutics Holding SA's collaborating partner NRx Pharmaceuticals Inc has announced that th","content":"<p><b>Relief Therapeutics Holding SA's</b>&nbsp;collaborating partner&nbsp;<b>NRx Pharmaceuticals Inc</b>&nbsp;has announced that the&nbsp;FDA has denied Breakthrough Therapy Designation&nbsp;for aviptadil.</p>\n<ul>\n <li>NRx noted that though the designation is not required for drug approval or emergency use authorization, but can afford faster review times, the ability to submit a rolling application, and dedicated FDA review personnel.</li>\n <li>Additionally, according to the CEO Update, the FDA has already granted priority and rolling review as part of the Fast Track Designation awarded in July 2020.</li>\n <li>Therefore, the denial does not impede NRx's ability to seek drug approval.</li>\n <li>Relief's lead drug candidate, RLF-100 (aviptadil), is a synthetic form of Vasoactive Intestinal Peptide (VIP).</li>\n <li>It is in late-stage clinical testing in the U.S. for respiratory deficiency due to COVID-19.<i>.</i></li>\n <li><b>Price Action:</b>&nbsp;NRXP shares closed 5.56% lower at $4.25 during after-hours trading on Tuesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-24 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/24269339/fda-denies-breakthrough-tag-for-nrx-pharmas-covid-19-candidate><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics Holding SA's collaborating partner NRx Pharmaceuticals Inc has announced that the FDA has denied Breakthrough Therapy Designation for aviptadil.\n\nNRx noted that though the ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/24269339/fda-denies-breakthrough-tag-for-nrx-pharmas-covid-19-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RLFTF":"RELIEF THERAPEUTICS HLDG AG","NRXP":"NRX Pharmaceuticals Inc."},"source_url":"https://www.benzinga.com/general/biotech/21/11/24269339/fda-denies-breakthrough-tag-for-nrx-pharmas-covid-19-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167653292","content_text":"Relief Therapeutics Holding SA's collaborating partner NRx Pharmaceuticals Inc has announced that the FDA has denied Breakthrough Therapy Designation for aviptadil.\n\nNRx noted that though the designation is not required for drug approval or emergency use authorization, but can afford faster review times, the ability to submit a rolling application, and dedicated FDA review personnel.\nAdditionally, according to the CEO Update, the FDA has already granted priority and rolling review as part of the Fast Track Designation awarded in July 2020.\nTherefore, the denial does not impede NRx's ability to seek drug approval.\nRelief's lead drug candidate, RLF-100 (aviptadil), is a synthetic form of Vasoactive Intestinal Peptide (VIP).\nIt is in late-stage clinical testing in the U.S. for respiratory deficiency due to COVID-19..\nPrice Action: NRXP shares closed 5.56% lower at $4.25 during after-hours trading on Tuesday.","news_type":1,"symbols_score_info":{"NRXP":0.9,"RLFTF":0.9}},"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":603920179,"gmtCreate":1638354224611,"gmtModify":1638354224839,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/603920179","repostId":"1101865893","repostType":4,"isVote":1,"tweetType":1,"viewCount":878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860350136,"gmtCreate":1632139650325,"gmtModify":1632802602449,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/860350136","repostId":"1194891884","repostType":4,"repost":{"id":"1194891884","kind":"news","pubTimestamp":1632091615,"share":"https://ttm.financial/m/news/1194891884?lang=&edition=full","pubTime":"2021-09-20 06:46","market":"us","language":"en","title":"Nike, Costco, FedEx, Salesforce, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1194891884","media":"Barrons","summary":"The main event this week will be the Federal Reserve’s September policy meeting. Investors will also","content":"<p>The main event this week will be the Federal Reserve’s September policy meeting. Investors will also be watching for several corporate earnings releases, investor days, and the latest economic data.</p>\n<p>Lennar reports quarterly earnings on Monday, followed by results from Adobe, AutoZone, and FedEx on Tuesday. General Mills goes on Wednesday, then Nike, Accenture, Costco Wholesale, and Darden Restaurants report&nbsp;on Thursday. Investor days this week include&nbsp;Biogen on Tuesday,&nbsp;Weyerhaeuser on Wednesday, and&nbsp;Salesforce.com on Thursday.</p>\n<p>The Federal Reserve’s monetary policy committee meets on Tuesday and Wednesday this week. The central bank is unlikely&nbsp;to change its target interest rate range, but could give an update on its plans to begin reducing its monthly asset purchases. Wednesday afternoon’s&nbsp;press conference with Fed chair Jerome Powell will be closely&nbsp;watched.</p>\n<p>Economic data out this week include the Conference Board’s Leading Economic Index for August on Thursday. There will also be several updates on the U.S. housing market including the National Association of Home Builders’ Housing Market Index for September on Monday, the Census Bureau’s new residential construction data for August on Tuesday, and the National Association of Realtors’&nbsp;existing-home sales for August on Wednesday.</p>\n<p><b>Monday 9/20</b></p>\n<p>Lennar reports third-quarter fiscal-2021 results.</p>\n<p>Merck presents data on its portfolio of cancer drugs, in conjunction with the European Society for Medical Oncology’s 2021 Congress.</p>\n<p><b>The National Association</b>&nbsp;of Home Builders releases its Housing Market Index for September. Economists forecast a 73 reading, two points below August’s figure, which was the lowest in more than a year.</p>\n<p><b>Tuesday 9/21</b></p>\n<p>Adobe, AutoZone, and FedEx release earnings.</p>\n<p>Biogen hosts an investor day to discuss its pipeline of neuroscience therapeutics.</p>\n<p><b>The Census Bureau</b>&nbsp;reports on new residential construction for August. Consensus estimate is for a seasonally adjusted annual rate of 1.55 million housing starts, 1% higher than the July level. Housing starts are down from their post–financial crisis peak of 1.725 million, reached in March of this year.</p>\n<p><b>Wednesday 9/22</b></p>\n<p><b>The FOMC announces</b>&nbsp;its monetary-policy decision. The Federal Reserve is likely to keep the federal-funds rate unchanged at near zero, but might signal that it will pare its asset purchases later this year.</p>\n<p>General Mills reports first-quarter fiscal-2022 results.</p>\n<p>Boston Scientific,Weyerhaeuser, and&nbsp;Yum China Holdings&nbsp;host their 2021 investor days.</p>\n<p><b>TheBank of Japan</b>&nbsp;announces its monetary-policy decision. The BOJ is widely expected to keep its key short-term interest rate unchanged at minus 0.1%, as Tokyo and other regions remain in a state of emergency through the end of September due to the Covid-19 Delta variant.</p>\n<p><b>The National Association</b>&nbsp;of Realtors reports existing-home sales for August. Expectations are for a seasonally adjusted annual rate of 578,000 homes sold, down 3.5%&nbsp;from July’s 599,000.</p>\n<p><b>Thursday 9/23</b></p>\n<p>Accenture, Costco Wholesale, Darden Restaurants, and Nike hold conference calls to discuss their quarterly results.</p>\n<p>Salesforce.com holds its 2021 investor day. CEO Marc Benioff and Slack CEO Stewart Butterfield will be among the participants. Salesforce completed its $28 billion acquisition of Slack this summer.</p>\n<p><b>The Conference Board</b>&nbsp;releases its Leading Economic Index for August. Economists forecast a 0.5% month-over-month rise, after a 0.9% increase in July. The Conference Board currently projects 6% gross-domestic-product growth for 2021, and 4% for 2022.</p>\n<p><b>Friday 9/24</b></p>\n<p>Kansas City Southernhosts a special shareholder meeting to vote on a proposed merger withCanadian Pacific Railway.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike, Costco, FedEx, Salesforce, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike, Costco, FedEx, Salesforce, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-20 06:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nike-costco-fedex-salesforce-and-other-stocks-for-investors-to-watch-this-week-51632078208?mod=hp_LEAD_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The main event this week will be the Federal Reserve’s September policy meeting. Investors will also be watching for several corporate earnings releases, investor days, and the latest economic data.\n...</p>\n\n<a href=\"https://www.barrons.com/articles/nike-costco-fedex-salesforce-and-other-stocks-for-investors-to-watch-this-week-51632078208?mod=hp_LEAD_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克",".SPX":"S&P 500 Index","ADBE":"Adobe",".DJI":"道琼斯","FDX":"联邦快递","CRM":"赛富时",".IXIC":"NASDAQ Composite","COST":"好市多"},"source_url":"https://www.barrons.com/articles/nike-costco-fedex-salesforce-and-other-stocks-for-investors-to-watch-this-week-51632078208?mod=hp_LEAD_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194891884","content_text":"The main event this week will be the Federal Reserve’s September policy meeting. Investors will also be watching for several corporate earnings releases, investor days, and the latest economic data.\nLennar reports quarterly earnings on Monday, followed by results from Adobe, AutoZone, and FedEx on Tuesday. General Mills goes on Wednesday, then Nike, Accenture, Costco Wholesale, and Darden Restaurants report on Thursday. Investor days this week include Biogen on Tuesday, Weyerhaeuser on Wednesday, and Salesforce.com on Thursday.\nThe Federal Reserve’s monetary policy committee meets on Tuesday and Wednesday this week. The central bank is unlikely to change its target interest rate range, but could give an update on its plans to begin reducing its monthly asset purchases. Wednesday afternoon’s press conference with Fed chair Jerome Powell will be closely watched.\nEconomic data out this week include the Conference Board’s Leading Economic Index for August on Thursday. There will also be several updates on the U.S. housing market including the National Association of Home Builders’ Housing Market Index for September on Monday, the Census Bureau’s new residential construction data for August on Tuesday, and the National Association of Realtors’ existing-home sales for August on Wednesday.\nMonday 9/20\nLennar reports third-quarter fiscal-2021 results.\nMerck presents data on its portfolio of cancer drugs, in conjunction with the European Society for Medical Oncology’s 2021 Congress.\nThe National Association of Home Builders releases its Housing Market Index for September. Economists forecast a 73 reading, two points below August’s figure, which was the lowest in more than a year.\nTuesday 9/21\nAdobe, AutoZone, and FedEx release earnings.\nBiogen hosts an investor day to discuss its pipeline of neuroscience therapeutics.\nThe Census Bureau reports on new residential construction for August. Consensus estimate is for a seasonally adjusted annual rate of 1.55 million housing starts, 1% higher than the July level. Housing starts are down from their post–financial crisis peak of 1.725 million, reached in March of this year.\nWednesday 9/22\nThe FOMC announces its monetary-policy decision. The Federal Reserve is likely to keep the federal-funds rate unchanged at near zero, but might signal that it will pare its asset purchases later this year.\nGeneral Mills reports first-quarter fiscal-2022 results.\nBoston Scientific,Weyerhaeuser, and Yum China Holdings host their 2021 investor days.\nTheBank of Japan announces its monetary-policy decision. The BOJ is widely expected to keep its key short-term interest rate unchanged at minus 0.1%, as Tokyo and other regions remain in a state of emergency through the end of September due to the Covid-19 Delta variant.\nThe National Association of Realtors reports existing-home sales for August. Expectations are for a seasonally adjusted annual rate of 578,000 homes sold, down 3.5% from July’s 599,000.\nThursday 9/23\nAccenture, Costco Wholesale, Darden Restaurants, and Nike hold conference calls to discuss their quarterly results.\nSalesforce.com holds its 2021 investor day. CEO Marc Benioff and Slack CEO Stewart Butterfield will be among the participants. Salesforce completed its $28 billion acquisition of Slack this summer.\nThe Conference Board releases its Leading Economic Index for August. Economists forecast a 0.5% month-over-month rise, after a 0.9% increase in July. The Conference Board currently projects 6% gross-domestic-product growth for 2021, and 4% for 2022.\nFriday 9/24\nKansas City Southernhosts a special shareholder meeting to vote on a proposed merger withCanadian Pacific Railway.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"ADBE":0.9,"COST":0.9,"CRM":0.9,"FDX":0.9,"NKE":0.9}},"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814027600,"gmtCreate":1630730601200,"gmtModify":1631890162227,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/814027600","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":206,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898583335,"gmtCreate":1628510522827,"gmtModify":1633746586387,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/898583335","repostId":"2158453784","repostType":4,"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899845798,"gmtCreate":1628175454914,"gmtModify":1633752904042,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/899845798","repostId":"1173170520","repostType":4,"isVote":1,"tweetType":1,"viewCount":102,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":845737086,"gmtCreate":1636367111604,"gmtModify":1636367111741,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/845737086","repostId":"2181724613","repostType":4,"repost":{"id":"2181724613","kind":"news","pubTimestamp":1636365600,"share":"https://ttm.financial/m/news/2181724613?lang=&edition=full","pubTime":"2021-11-08 18:00","market":"us","language":"en","title":"Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2181724613","media":"GlobeNewswire","summary":"– One of the largest private financings of a UK biotech company, and the largest from a single sourc","content":"<p><i>– One of the largest private financings of a UK biotech company, and the largest from a single source – continues Blackstone conviction in the country</i></p>\n<p><i>– Durability and favorable toxicity profile of obe-cel supports its potential as the first stand-alone therapy in adult ALL with curative potential in a last line setting </i></p>\n<p><i>– Blackstone strategic financing to enable Autolus to complete clinical development of obe-cel in its first indication of relapsed / refractory adult ALL and to support initial pre-approval commercial activities </i></p>\n<p>LONDON and CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc&nbsp;(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, and Blackstone&nbsp;Life Sciences today announced that the two companies have entered into a strategic collaboration and financing agreement under which funds managed by&nbsp;Blackstone (NYSE: BX) will provide up to $250 million in equity and product financing to support Autolus’ advancement of its CD19 CAR T cell investigational therapy product candidate, obecabtagene autoleucel (obe-cel), as well as next generation product therapies of obe-cel in B-cell malignancies.</p>\n<p>As part of this $250 million transaction, Blackstone is committing to invest $150 million in product financing to support obe-cel development and commercialization, with $50 million payable upon closing of the transaction and the remainder payable based on certain development and regulatory achievements. Blackstone has also agreed to purchase $100 million of Autolus’ American Depositary Shares (ADS) in a private placement, which is subject to customary closing conditions. In connection with the collaboration, Blackstone received the right to nominate a member to Autolus’ board of directors.</p>\n<p>The transaction continues Blackstone’s commitment to the UK economy which has seen the firm invest more than $18 billion across 44 investments headquartered in UK. These investments support more than 27,000 direct jobs and help make Blackstone the UK’s biggest foreign investor over the past 10 years.</p>\n<p>“Autolus is a world-class company with an innovative platform and the potential to deliver best-in-class, lifesaving treatments to patients suffering from cancer,” said Dr. Nicholas Galakatos, Global Head of Blackstone Life Sciences. “Our investment in these next generation cell therapies exemplify our conviction in the quality and promise of the life sciences sector in the UK. We look forward to building on this investment in the years to come.”</p>\n<p>“We welcome Blackstone Life Sciences to join our drive to change the outlook for leukemia and lymphoma patients, notably those with acute lymphoblastic leukemia. Blackstone’s investment and expertise will support the development and preparation for commercialization of obe-cel and put the program and the Company on a strong financial footing as we are approaching the read-out from the potentially pivotal FELIX clinical trial during the course of 2022,” said Dr. Christian Itin, Chief Executive Officer of Autolus.</p>\n<p>“We are excited to collaborate with Autolus in support of their innovative platform pursuing safer, more durable, therapies with the potential to be lifesaving options for patients with ALL and beyond. We see a significant opportunity to improve the outlook for cancer patients who are facing a devastating course of their disease,” said Nicholas Simon, Senior Managing Director of Blackstone Life Sciences. “This investment continues to build on our conviction in not just innovative cell and gene therapies, but also supporting innovation in the United Kingdom and Europe broadly.”</p>\n<p>UK Science Minister George Freeman said: “This is another vote of confidence in the quality of life science in the UK, reinforcing our reputation as a world leader in discovering new cures for currently untreatable diseases like Autolus’ T cell therapy drugs for leukemia. Big investments like these give real hope to those suffering from diseases like leukemia - and create high skill jobs &amp; opportunities in the development and manufacturing of treatments to help develop and boost our life science clusters all around the UK.”</p>\n<p>Autolus recently announced plans to build a dedicated manufacturing facility in Stevenage, UK to help secure global commercial launch capacity for obe-cel with a 70,000 square foot building. The ground-breaking ceremony for this new facility is due to be held today, with building works commencing imminently.</p>\n<p>Moelis &amp; Company LLC acted as financial advisor. Cooley LLP and Cooley (UK) LLP acted as legal advisor to Autolus, and Goodwin Procter LLP acted as legal advisor to Blackstone.</p>\n<p><b>About the Transaction</b></p>\n<p>The strategic financing collaboration by Autolus and Blackstone Life Sciences is expected to support the development and preparation for commercialization of Autolus’ product candidate, obe-cel. As part of this $250 million transaction, Blackstone is committing to invest an aggregate of $150 million in product financing to support Autolus’ development and potential commercialization of obe-cel, with $50 million payable upon closing of the transaction and the remainder (up to $100 million) payable based on certain development and regulatory achievements. In return for this strategic investment, Autolus has agreed to pay Blackstone a capped single digit royalty plus milestone payments based on net sales of obe‐cel. In addition, Blackstone will receive a warrant to purchase up to $24 million worth of Autolus ADSs at an exercise price premium to market. Blackstone has also agreed to make a $100 million equity investment in Autolus which is expected to close on or about November 12, 2021, subject to customary closing conditions. In connection with the collaboration, Blackstone received the right to nominate a member to Autolus’ board of directors.</p>\n<p><b>About Autolus Therapeutics plc</b></p>\n<p>Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, please visit www.autolus.com.</p>\n<p><b>About obe-cel&nbsp;(obecabtagene autoleucel)</b></p>\n<p>Obe-cel is a CD19 CAR T cell investigational therapy designed to overcome the limitations in clinical activity and safety compared to current CD19 CAR T cell therapies.&nbsp;Designed to have a fast target binding off-rate to minimize excessive activation of the programmed T cells, obe-cel may reduce toxicity and be less prone to T cell exhaustion, which could enhance persistence and improve the ability of the programmed T cells to engage in serial killing of target cancer cells. Obe-cel is currently being evaluated in a potentially pivotal Phase 1b/2 clinical trial for the treatment of adult ALL, referred to as the FELIX clinical trial. Also, in collaboration with Autolus’ academic partner, UCL, obe-cel is currently being evaluated in a Phase 1 clinical trial in B-NHL.</p>\n<p><b>About obe-cel</b> <b>FELIX clinical trial</b></p>\n<p>Autolus’ Phase 1b/2 clinical trial of obe-cel, or the FELIX clinical trial, is enrolling adult patients with relapsed / refractory ALL. The trial had a short Phase 1b component prior to proceeding to a single arm, Phase 2 clinical trial. The primary endpoint is overall response rate, and the key secondary endpoints include duration of response, MRD negative CR rate and safety. The trial is designed to enroll approximately 100 patients across 30 of the leading academic and non-academic centers in the United States,&nbsp;United Kingdom&nbsp;and&nbsp;Europe. [NCT04404660]</p>\n<p><b>About Blackstone Life Sciences</b></p>\n<p>Blackstone Life Sciences is an industry-leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines and medical technologies that improve patients’ lives. More information is provided at https://www.blackstone.com/our-businesses/life-sciences/.</p>\n<p><b>Forward-Looking Statements</b></p>\n<p>This press release contains forward-looking statements within the meaning of the \"safe harbor\" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as \"may,\" \"will,\" \"could,\" \"expects,\" \"plans,\" \"anticipates,\" and \"believes.\" These statements include, but are not limited to, statements regarding the collaboration between Autolus and Blackstone; the future clinical development, efficacy, safety and therapeutic potential of obe-cel, including progress, expectations as to the reporting of data, conduct and timing and potential future clinical activity; the ability of the FELIX trial to be a registrational trial; the receipt of regulatory approval from the U.S. Food and Drug Administration for obe-cel; the discovery, development and potential commercialization of potential product candidates including obe-cel using Autolus’ technology and under the collaboration agreement; the therapeutic potential for Autolus in next generation product developments of obe-cel in B-cell malignancies; the potential and timing to receive milestone payments and pay royalties under the strategic collaboration; expectations regarding the expected use of proceeds from the collaboration and financing arrangement with Blackstone; and the completion of the offering of Autolus securities. Any forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, the risks that Autolus’ preclinical or clinical programs do not advance or result in approved products on a timely or cost effective basis or at all; the results of early clinical trials are not always being predictive of future results; the cost, timing and results of clinical trials; that many product candidates do not become approved drugs on a timely or cost effective basis or at all; the ability to enroll patients in clinical trials; possible safety and efficacy concerns; and the impact of the ongoing COVID-19 pandemic on Autolus’ business. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Autolus’ actual results to differ from those contained in the forward-looking statements, see the section titled \"Risk Factors\" in Autolus’ Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 4, 2021, as well as discussions of potential risks, uncertainties, and other important factors in Autolus’ subsequent filings with the Securities and Exchange Commission including its Reports on Form 6-K. All information in this press release is as of the date of the release, and Autolus undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-08 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/blackstone-life-sciences-invest-250-070000067.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>– One of the largest private financings of a UK biotech company, and the largest from a single source – continues Blackstone conviction in the country\n– Durability and favorable toxicity profile of ...</p>\n\n<a href=\"https://finance.yahoo.com/news/blackstone-life-sciences-invest-250-070000067.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BX":"黑石","AUTL":"Autolus Therapeutics PLC"},"source_url":"https://finance.yahoo.com/news/blackstone-life-sciences-invest-250-070000067.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2181724613","content_text":"– One of the largest private financings of a UK biotech company, and the largest from a single source – continues Blackstone conviction in the country\n– Durability and favorable toxicity profile of obe-cel supports its potential as the first stand-alone therapy in adult ALL with curative potential in a last line setting \n– Blackstone strategic financing to enable Autolus to complete clinical development of obe-cel in its first indication of relapsed / refractory adult ALL and to support initial pre-approval commercial activities \nLONDON and CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, and Blackstone Life Sciences today announced that the two companies have entered into a strategic collaboration and financing agreement under which funds managed by Blackstone (NYSE: BX) will provide up to $250 million in equity and product financing to support Autolus’ advancement of its CD19 CAR T cell investigational therapy product candidate, obecabtagene autoleucel (obe-cel), as well as next generation product therapies of obe-cel in B-cell malignancies.\nAs part of this $250 million transaction, Blackstone is committing to invest $150 million in product financing to support obe-cel development and commercialization, with $50 million payable upon closing of the transaction and the remainder payable based on certain development and regulatory achievements. Blackstone has also agreed to purchase $100 million of Autolus’ American Depositary Shares (ADS) in a private placement, which is subject to customary closing conditions. In connection with the collaboration, Blackstone received the right to nominate a member to Autolus’ board of directors.\nThe transaction continues Blackstone’s commitment to the UK economy which has seen the firm invest more than $18 billion across 44 investments headquartered in UK. These investments support more than 27,000 direct jobs and help make Blackstone the UK’s biggest foreign investor over the past 10 years.\n“Autolus is a world-class company with an innovative platform and the potential to deliver best-in-class, lifesaving treatments to patients suffering from cancer,” said Dr. Nicholas Galakatos, Global Head of Blackstone Life Sciences. “Our investment in these next generation cell therapies exemplify our conviction in the quality and promise of the life sciences sector in the UK. We look forward to building on this investment in the years to come.”\n“We welcome Blackstone Life Sciences to join our drive to change the outlook for leukemia and lymphoma patients, notably those with acute lymphoblastic leukemia. Blackstone’s investment and expertise will support the development and preparation for commercialization of obe-cel and put the program and the Company on a strong financial footing as we are approaching the read-out from the potentially pivotal FELIX clinical trial during the course of 2022,” said Dr. Christian Itin, Chief Executive Officer of Autolus.\n“We are excited to collaborate with Autolus in support of their innovative platform pursuing safer, more durable, therapies with the potential to be lifesaving options for patients with ALL and beyond. We see a significant opportunity to improve the outlook for cancer patients who are facing a devastating course of their disease,” said Nicholas Simon, Senior Managing Director of Blackstone Life Sciences. “This investment continues to build on our conviction in not just innovative cell and gene therapies, but also supporting innovation in the United Kingdom and Europe broadly.”\nUK Science Minister George Freeman said: “This is another vote of confidence in the quality of life science in the UK, reinforcing our reputation as a world leader in discovering new cures for currently untreatable diseases like Autolus’ T cell therapy drugs for leukemia. Big investments like these give real hope to those suffering from diseases like leukemia - and create high skill jobs & opportunities in the development and manufacturing of treatments to help develop and boost our life science clusters all around the UK.”\nAutolus recently announced plans to build a dedicated manufacturing facility in Stevenage, UK to help secure global commercial launch capacity for obe-cel with a 70,000 square foot building. The ground-breaking ceremony for this new facility is due to be held today, with building works commencing imminently.\nMoelis & Company LLC acted as financial advisor. Cooley LLP and Cooley (UK) LLP acted as legal advisor to Autolus, and Goodwin Procter LLP acted as legal advisor to Blackstone.\nAbout the Transaction\nThe strategic financing collaboration by Autolus and Blackstone Life Sciences is expected to support the development and preparation for commercialization of Autolus’ product candidate, obe-cel. As part of this $250 million transaction, Blackstone is committing to invest an aggregate of $150 million in product financing to support Autolus’ development and potential commercialization of obe-cel, with $50 million payable upon closing of the transaction and the remainder (up to $100 million) payable based on certain development and regulatory achievements. In return for this strategic investment, Autolus has agreed to pay Blackstone a capped single digit royalty plus milestone payments based on net sales of obe‐cel. In addition, Blackstone will receive a warrant to purchase up to $24 million worth of Autolus ADSs at an exercise price premium to market. Blackstone has also agreed to make a $100 million equity investment in Autolus which is expected to close on or about November 12, 2021, subject to customary closing conditions. In connection with the collaboration, Blackstone received the right to nominate a member to Autolus’ board of directors.\nAbout Autolus Therapeutics plc\nAutolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. For more information, please visit www.autolus.com.\nAbout obe-cel (obecabtagene autoleucel)\nObe-cel is a CD19 CAR T cell investigational therapy designed to overcome the limitations in clinical activity and safety compared to current CD19 CAR T cell therapies. Designed to have a fast target binding off-rate to minimize excessive activation of the programmed T cells, obe-cel may reduce toxicity and be less prone to T cell exhaustion, which could enhance persistence and improve the ability of the programmed T cells to engage in serial killing of target cancer cells. Obe-cel is currently being evaluated in a potentially pivotal Phase 1b/2 clinical trial for the treatment of adult ALL, referred to as the FELIX clinical trial. Also, in collaboration with Autolus’ academic partner, UCL, obe-cel is currently being evaluated in a Phase 1 clinical trial in B-NHL.\nAbout obe-cel FELIX clinical trial\nAutolus’ Phase 1b/2 clinical trial of obe-cel, or the FELIX clinical trial, is enrolling adult patients with relapsed / refractory ALL. The trial had a short Phase 1b component prior to proceeding to a single arm, Phase 2 clinical trial. The primary endpoint is overall response rate, and the key secondary endpoints include duration of response, MRD negative CR rate and safety. The trial is designed to enroll approximately 100 patients across 30 of the leading academic and non-academic centers in the United States, United Kingdom and Europe. [NCT04404660]\nAbout Blackstone Life Sciences\nBlackstone Life Sciences is an industry-leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines and medical technologies that improve patients’ lives. More information is provided at https://www.blackstone.com/our-businesses/life-sciences/.\nForward-Looking Statements\nThis press release contains forward-looking statements within the meaning of the \"safe harbor\" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as \"may,\" \"will,\" \"could,\" \"expects,\" \"plans,\" \"anticipates,\" and \"believes.\" These statements include, but are not limited to, statements regarding the collaboration between Autolus and Blackstone; the future clinical development, efficacy, safety and therapeutic potential of obe-cel, including progress, expectations as to the reporting of data, conduct and timing and potential future clinical activity; the ability of the FELIX trial to be a registrational trial; the receipt of regulatory approval from the U.S. Food and Drug Administration for obe-cel; the discovery, development and potential commercialization of potential product candidates including obe-cel using Autolus’ technology and under the collaboration agreement; the therapeutic potential for Autolus in next generation product developments of obe-cel in B-cell malignancies; the potential and timing to receive milestone payments and pay royalties under the strategic collaboration; expectations regarding the expected use of proceeds from the collaboration and financing arrangement with Blackstone; and the completion of the offering of Autolus securities. Any forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, the risks that Autolus’ preclinical or clinical programs do not advance or result in approved products on a timely or cost effective basis or at all; the results of early clinical trials are not always being predictive of future results; the cost, timing and results of clinical trials; that many product candidates do not become approved drugs on a timely or cost effective basis or at all; the ability to enroll patients in clinical trials; possible safety and efficacy concerns; and the impact of the ongoing COVID-19 pandemic on Autolus’ business. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Autolus’ actual results to differ from those contained in the forward-looking statements, see the section titled \"Risk Factors\" in Autolus’ Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 4, 2021, as well as discussions of potential risks, uncertainties, and other important factors in Autolus’ subsequent filings with the Securities and Exchange Commission including its Reports on Form 6-K. All information in this press release is as of the date of the release, and Autolus undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.","news_type":1,"symbols_score_info":{"AUTL":0.9,"BX":0.9}},"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841546164,"gmtCreate":1635928803007,"gmtModify":1635928803107,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/841546164","repostId":"1178338626","repostType":4,"repost":{"id":"1178338626","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635928227,"share":"https://ttm.financial/m/news/1178338626?lang=&edition=full","pubTime":"2021-11-03 16:30","market":"us","language":"en","title":"Some meme stocks skyrocketed in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1178338626","media":"Tiger Newspress","summary":"Some meme stocks skyrocketed in premarket trading.Bed Bath & Beyond,R.R. Donnelley & Sons,Naked Bran","content":"<p>Some meme stocks skyrocketed in premarket trading.Bed Bath &amp; Beyond,R.R. Donnelley &amp; Sons,Naked Brand,Koss,Express,AMC,GameStop&nbsp;and&nbsp;BlackBerry&nbsp;soared between 4% and 62%.</p>\n<p><img src=\"https://static.tigerbbs.com/b016995062645d8011221cff13a86966\" tg-width=\"404\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/NW/1113177921\" target=\"_blank\">Bed Bath &amp; Beyond</a>,the home-goods retailer announced news that likely fueled a so-called short squeeze, where hedge funds that had bet against the stock were forced to buy back their shares to cut losses.</p>\n<p>Commercial-printing company&nbsp;R.R. Donnelley &amp; Sons&nbsp;Co.&nbsp;is nearing a deal to sell itself to a private-equity firm for just over $2 billion including debt, according to people familiar with the matter.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some meme stocks skyrocketed in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome meme stocks skyrocketed in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-03 16:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some meme stocks skyrocketed in premarket trading.Bed Bath &amp; Beyond,R.R. Donnelley &amp; Sons,Naked Brand,Koss,Express,AMC,GameStop&nbsp;and&nbsp;BlackBerry&nbsp;soared between 4% and 62%.</p>\n<p><img src=\"https://static.tigerbbs.com/b016995062645d8011221cff13a86966\" tg-width=\"404\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p>\n<p><a href=\"https://laohu8.com/NW/1113177921\" target=\"_blank\">Bed Bath &amp; Beyond</a>,the home-goods retailer announced news that likely fueled a so-called short squeeze, where hedge funds that had bet against the stock were forced to buy back their shares to cut losses.</p>\n<p>Commercial-printing company&nbsp;R.R. Donnelley &amp; Sons&nbsp;Co.&nbsp;is nearing a deal to sell itself to a private-equity firm for just over $2 billion including debt, according to people familiar with the matter.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EXPR":"Express, Inc.","GME":"游戏驿站","KOSS":"高斯电子","BBBY":"3B家居","RRD":"当纳利","AMC":"AMC院线","BB":"黑莓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178338626","content_text":"Some meme stocks skyrocketed in premarket trading.Bed Bath & Beyond,R.R. Donnelley & Sons,Naked Brand,Koss,Express,AMC,GameStop and BlackBerry soared between 4% and 62%.\n\nBed Bath & Beyond,the home-goods retailer announced news that likely fueled a so-called short squeeze, where hedge funds that had bet against the stock were forced to buy back their shares to cut losses.\nCommercial-printing company R.R. Donnelley & Sons Co. is nearing a deal to sell itself to a private-equity firm for just over $2 billion including debt, according to people familiar with the matter.","news_type":1,"symbols_score_info":{"AMC":0.9,"BB":0.9,"BBBY":0.9,"EXPR":0.9,"GME":0.9,"KOSS":0.9,"NAKD":0.9,"RRD":0.9}},"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858259874,"gmtCreate":1635062861315,"gmtModify":1635062861453,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/858259874","repostId":"1174514229","repostType":4,"repost":{"id":"1174514229","kind":"news","pubTimestamp":1635035471,"share":"https://ttm.financial/m/news/1174514229?lang=&edition=full","pubTime":"2021-10-24 08:31","market":"us","language":"en","title":"US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174514229","media":"Renaissance Capital","summary":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.","content":"<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.</p>\n<p>Semiconductor foundry&nbsp;<b>GlobalFoundries</b>(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.</p>\n<p>Enterprise cloud data management platform&nbsp;<b>Informatica</b>(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.</p>\n<p>Energy storage provider&nbsp;<b>Fluence Energy</b>(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.</p>\n<p>Revenue cycle management platform&nbsp;<b>Ensemble Health Partners</b>(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.</p>\n<p>Hiring solutions provider&nbsp;<b>HireRight Holdings</b>(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.</p>\n<p>Online education marketplace&nbsp;<b>Udemy</b>(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.</p>\n<p>Chinese drug in-licensor&nbsp;<b>LianBio</b>(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.</p>\n<p><b>Rent the Runway</b>(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.</p>\n<p>Aesthetic medical device maker&nbsp;<b>Candela Medical</b>(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.</p>\n<p>Fire pit brand&nbsp;<b>Solo Brands</b>(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.</p>\n<p>Body contouring provider&nbsp;<b>AirSculpt Technologies</b>(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.</p>\n<p>Technology firm&nbsp;<b>Arteris</b>(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.</p>\n<p><img src=\"https://static.tigerbbs.com/99c3b0173e59f4e69ff484c12bd137e7\" tg-width=\"1270\" tg-height=\"704\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/64e34b3c49a856e99ba64a2d57410844\" tg-width=\"1272\" tg-height=\"582\" referrerpolicy=\"no-referrer\"></p>\n<p>Street research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&amp;P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Semiconductors, energy storage, designer apparel, and more in a 12 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","AIRS":"Airsculpt Technologies",".DJI":"道琼斯","AIP":"Arteris, Inc.","DTC":"Solo Brands, Inc.","GFS":"GLOBALFOUNDRIES Inc.","RENT":"Rent the Runway, Inc.","INFA":"Informatica Inc.","HRT":"HireRight Holdings Corp.",".IXIC":"NASDAQ Composite","FLNC":"Fluence Energy, Inc.","UDMY":"Udemy, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87676/US-IPO-Week-Ahead-Semiconductors-energy-storage-designer-apparel-and-more-i","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174514229","content_text":"The IPO market continues to stay busy with 12 IPOs schedule to raise $6.8 billion in the week ahead.\nSemiconductor foundry GlobalFoundries(GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty semiconductor foundries. Unprofitable with lumpy growth, the company states that it is the only scaled pure-play foundry with a global footprint that is not based in China.\nEnterprise cloud data management platform Informatica(INFA) plans to raise $885 million at an $8.7 billion market cap. This company provides data integration services on its AI-powered platform to over 5,700 customers through both licenses and subscriptions. Although it will be highly leveraged post-IPO, Informatica is a recognized leader in the global data management market and saw strong subscription ARR growth in the 1H21.\nEnergy storage provider Fluence Energy(FLNC) plans to raise $698 million at a $3.8 billion market cap. Formed by Siemens and AES, this company sells energy storage products and services to utilities, independent power producers, project developers, and commercial and industrial customers. Fast growing but unprofitable, Fluence Energy deployed 942 MW of storage products as of 6/30/21.\nRevenue cycle management platform Ensemble Health Partners(ENSB) plans to raise $605 million at a $3.6 billion market cap. This platform provides revenue cycle management solutions to the healthcare industry. Profitable with accelerating growth in the 1H21, Ensemble Health has over $20 billion in annual client net patient revenue under management.\nHiring solutions provider HireRight Holdings(HRT) plans to raise $500 million at a $1.8 billion market cap. This company provides background checks, verification, identification, monitoring, and drug and health screening services to over 40,000 customers. HireRight was profitable on an EBIT basis in the 1H21, though cash flow swung negative.\nOnline education marketplace Udemy(UDMY) plans to raise $406 million at a $4.3 billion market cap. This education platform provides over 183,000 courses in 75 languages to over 44 million customers in over 180 countries. Growing but unprofitable, Udemy has registered more than 73 million users since its inception.\nChinese drug in-licensor LianBio(LIAN) plans to raise $325 million at a $1.8 billion market cap. Focused on China and other Asian markets, this biopharmaceutical company develops and commercializes drugs for a variety of indications. LianBio’s pipeline currently consists of nine product candidates across five different therapeutics areas.\nRent the Runway(RENT) plans to raise $293 million at a $1.4 billion market cap. This apparel rental company originally focused on a-la-carte rentals of dresses for events, but has gradually transitioned to mostly generating revenue from monthly subscription boxes. While the company has seen active subscribers and revenue rebound in the last two quarters, it is unprofitable and leveraged post-IPO.\nAesthetic medical device maker Candela Medical(CDLA) plans to raise $250 million at a $1.7 billion market cap. Selling products directly in 18 countries and indirectly in 66 countries, this company develops medical devices for elective aesthetic procedures. Despite being hard hit by the pandemic, Candela Medical saw strong growth and turned profitable in the 1H21.\nFire pit brand Solo Brands(DTC) plans to raise $200 million at a $1.5 billion market cap. Solo Brands sells fire pits, camp stoves, and other outdoor gear through its DTC platform. Fast growing and profitable, this outdoor e-commerce has an installed base of more than 2.3 million customers.\nBody contouring provider AirSculpt Technologies(AIRS) plans to raise $160 million at an $886 million market cap. This company provides minimally-invasive body contouring procedures through 16 centers across 13 states in the US. AirSculpt Technologies is profitable with solid growth, and has seen an increase in same-center case volume as a result of lessening effects of COVID-19.\nTechnology firm Arteris(AIP) plans to raise $75 million at a $555 million market cap. This technology company develops and licenses interconnect intellectual property that manages the on-chip communications in System-on-Chip semiconductor devices. Arteris is unprofitable but saw growth accelerate in the 1H21.\n\nStreet research is expected for six companies, and lock-up periods will be expiring for up to 12 companies.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 10/22/21, the Renaissance IPO Index was up 8.2% year-to-date, while the S&P 500 was up 21.1%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber Technologies (UBER) and Moderna (MRNA). The Renaissance International IPO Index was down 15.8% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AIP":0.9,"AIRS":0.9,"CDLA":0.9,"DTC":0.9,"ENSB":0.9,"FLNC":0.9,"GFS":0.9,"HRT":0.9,"INFA":0.9,"LIAN":0.9,"RENT":0.9,"UDMY":0.9}},"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":807749206,"gmtCreate":1628062083105,"gmtModify":1633753938244,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/807749206","repostId":"1126131791","repostType":4,"isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":691693542,"gmtCreate":1640179454094,"gmtModify":1640179454686,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691693542","repostId":"1158577227","repostType":4,"repost":{"id":"1158577227","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640178165,"share":"https://ttm.financial/m/news/1158577227?lang=&edition=full","pubTime":"2021-12-22 21:02","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158577227","media":"Tiger Newspress","summary":"U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally","content":"<p>U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.</p>\n<p>At 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&amp;P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/512d5749bf54708c7063a6e721fa99f2\" tg-width=\"960\" tg-height=\"329\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p>Wall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&amp;P 500 index&nbsp;is up roughly 24% in 2021.</p>\n<p>Investors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/KMX\">CarMax</a> (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.</p>\n<p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a> (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.</p>\n<p><a href=\"https://laohu8.com/S/CAT\">Caterpillar</a> (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.</p>\n<p><a href=\"https://laohu8.com/S/CAMP\">CalAmp</a> (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.</p>\n<p><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a> (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a> (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.</p>\n<p><a href=\"https://laohu8.com/S/COIN\">Coinbase Global, Inc.</a> (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-22 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.</p>\n<p>At 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&amp;P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/512d5749bf54708c7063a6e721fa99f2\" tg-width=\"960\" tg-height=\"329\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p>Wall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&amp;P 500 index&nbsp;is up roughly 24% in 2021.</p>\n<p>Investors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/KMX\">CarMax</a> (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.</p>\n<p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a> (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.</p>\n<p><a href=\"https://laohu8.com/S/CAT\">Caterpillar</a> (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.</p>\n<p><a href=\"https://laohu8.com/S/CAMP\">CalAmp</a> (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.</p>\n<p><a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a> (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a> (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.</p>\n<p><a href=\"https://laohu8.com/S/COIN\">Coinbase Global, Inc.</a> (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158577227","content_text":"U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.\nAt 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.\n*Source From Tiger Trade, EST 08:00\nWall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&P 500 index is up roughly 24% in 2021.\nInvestors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.\nStocks making the biggest moves in the premarket:\nCarMax (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.\nTesla Motors (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.\nBlackBerry (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.\nCaterpillar (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.\nCalAmp (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.\nAlibaba (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.\nDarden Restaurants (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.\nWilliams-Sonoma (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.\nCoinbase Global, Inc. (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.","news_type":1,"symbols_score_info":{".DJI":0,".IXIC":0,".SPX":0,"ESmain":0,"NQmain":0,"YMmain":0}},"isVote":1,"tweetType":1,"viewCount":2376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":883401389,"gmtCreate":1631261237141,"gmtModify":1631890162214,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883401389","repostId":"2166310555","repostType":4,"repost":{"id":"2166310555","kind":"highlight","pubTimestamp":1631259300,"share":"https://ttm.financial/m/news/2166310555?lang=&edition=full","pubTime":"2021-09-10 15:35","market":"us","language":"en","title":"4 Reasons Why You Shouldn't Max Out Your 401(k)","url":"https://stock-news.laohu8.com/highlight/detail?id=2166310555","media":"Motley Fool","summary":"Consider these points before maxing out your 401(k).","content":"<blockquote>\n <b>Consider these points before maxing out your 401(k).</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Contributing to a retirement account isn’t the only way to build long-term financial security.</li>\n <li>A 401(k) is a powerful way to save money for retirement, but consider it relative to your other financial needs.</li>\n</ul>\n<p>The standard advice to maximize your 401(k) is excellent, but it doesn't suit everyone all the time. There are a few reasons why contributing as much as you can to your retirement fund might not make sense, at least not some years. That's because a traditional 401(k) locks your money away until you are 59 ½. Early withdrawal is allowed, but only in limited circumstances or with a tax penalty. It is not the only way to set aside money for retirement, either.</p>\n<p><img src=\"https://static.tigerbbs.com/a609ea45e588dde78d508439e00866e4\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p>\n<p>Image Source: Getty Images</p>\n<p>1. You have high-interest debt</p>\n<p>Early in your career, you might have high-cost debt to address. If you have high interest debt, such as credit cards or installment loans with interest rates above 15%, it may be best to concentrate on paying that off before contributing too much to your 401(k).</p>\n<p>Also, if you are having trouble making the minimum payments on student loans or scramble to pay your rent every month, you may not have enough slack in your budget. Contributing to a retirement plan could actually hurt you in the near term. Look for ways to increase your income or reduce your spending before committing to long-term savings. Eventually, you should be able to afford to put enough money into your retirement to earn any employer match offered, then build to a full contribution.</p>\n<p>2. You want to retire early</p>\n<p>Some people want to retire before the age of 59 ½. If this is you, it's a good idea to have money outside of traditional retirement accounts. For some, this will involve aggressive savings (the Financially Independent, Retired Early crowd). For others, it's simply having money set aside for a year or two before traditional retirement accounts can be tapped. If early retirement is your goal, consider slowing down your 401(k) contributions once your account balance is adequate. It may be better to put your money in taxable accounts rather than pay the 10% penalty tax on early withdrawals.</p>\n<p>3. You want to avoid huge required minimum distributions</p>\n<p>Once you turn 72, the IRS requires you to take a minimum amount from IRA and 401(k) accounts. This required minimum distribution is based on the account value and your age. For most people, this is not a concern; they are more concerned about having enough money in their retirement accounts, not having too much.</p>\n<p>A fortunate few find these required minimum withdrawals to be far larger than they want. If you have made maximum contributions for years, had success in the financial markets, and possibly have large deferred compensation funds in rollover IRA accounts that are included in the minimum distribution requirements, you may end up with ridiculously large RMDs and tax bills.</p>\n<p>If you're part of this minority of folks who may be forced to withdraw more money than they know what to do with, curtailing retirement contributions may be a good idea. You can put your savings into other investment vehicles, or consider giving it to charity to share your bounty.</p>\n<p>4. You're considering health care and long-term care</p>\n<p>Many retirees have high health-care costs. Medicare is a pretty good deal, but it doesn't cover everything. A health savings account is a tax-advantaged way to save for copayments, deductibles, vision care, and dental care. If you are eligible for a health savings account with your current health insurance, and if your retirement accounts are in good shape, consider maxing out your HSA contribution. The funds should roll over and be in place for you when you retire. The maximum HSA contribution for 2021 is $3600 for an individual and $7200 for a married couple filing jointly.</p>\n<p>Long-term care is especially expensive, whether it involves help at home, assisted living, or a skilled nursing facility. Long-term care insurance is available and is relatively inexpensive the younger that you are. If your basic retirement needs are covered, buying a long-term care policy instead of making a 401(k) contribution may be a good bet.</p>\n<p>By all means, maximize your 401(k) contribution if it makes sense, and participate just enough to get any employer match (free money!). But if you find yourself identifying with any of the points above, you may want to consider saving for retirement in a different way, at least for now.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Reasons Why You Shouldn't Max Out Your 401(k)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Reasons Why You Shouldn't Max Out Your 401(k)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 15:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/09/4-reasons-why-you-shouldnt-max-out-your-401k/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Consider these points before maxing out your 401(k).\n\nKey Points\n\nContributing to a retirement account isn’t the only way to build long-term financial security.\nA 401(k) is a powerful way to save ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/09/4-reasons-why-you-shouldnt-max-out-your-401k/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index","SPY":"标普500ETF"},"source_url":"https://www.fool.com/investing/2021/09/09/4-reasons-why-you-shouldnt-max-out-your-401k/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2166310555","content_text":"Consider these points before maxing out your 401(k).\n\nKey Points\n\nContributing to a retirement account isn’t the only way to build long-term financial security.\nA 401(k) is a powerful way to save money for retirement, but consider it relative to your other financial needs.\n\nThe standard advice to maximize your 401(k) is excellent, but it doesn't suit everyone all the time. There are a few reasons why contributing as much as you can to your retirement fund might not make sense, at least not some years. That's because a traditional 401(k) locks your money away until you are 59 ½. Early withdrawal is allowed, but only in limited circumstances or with a tax penalty. It is not the only way to set aside money for retirement, either.\n\nImage Source: Getty Images\n1. You have high-interest debt\nEarly in your career, you might have high-cost debt to address. If you have high interest debt, such as credit cards or installment loans with interest rates above 15%, it may be best to concentrate on paying that off before contributing too much to your 401(k).\nAlso, if you are having trouble making the minimum payments on student loans or scramble to pay your rent every month, you may not have enough slack in your budget. Contributing to a retirement plan could actually hurt you in the near term. Look for ways to increase your income or reduce your spending before committing to long-term savings. Eventually, you should be able to afford to put enough money into your retirement to earn any employer match offered, then build to a full contribution.\n2. You want to retire early\nSome people want to retire before the age of 59 ½. If this is you, it's a good idea to have money outside of traditional retirement accounts. For some, this will involve aggressive savings (the Financially Independent, Retired Early crowd). For others, it's simply having money set aside for a year or two before traditional retirement accounts can be tapped. If early retirement is your goal, consider slowing down your 401(k) contributions once your account balance is adequate. It may be better to put your money in taxable accounts rather than pay the 10% penalty tax on early withdrawals.\n3. You want to avoid huge required minimum distributions\nOnce you turn 72, the IRS requires you to take a minimum amount from IRA and 401(k) accounts. This required minimum distribution is based on the account value and your age. For most people, this is not a concern; they are more concerned about having enough money in their retirement accounts, not having too much.\nA fortunate few find these required minimum withdrawals to be far larger than they want. If you have made maximum contributions for years, had success in the financial markets, and possibly have large deferred compensation funds in rollover IRA accounts that are included in the minimum distribution requirements, you may end up with ridiculously large RMDs and tax bills.\nIf you're part of this minority of folks who may be forced to withdraw more money than they know what to do with, curtailing retirement contributions may be a good idea. You can put your savings into other investment vehicles, or consider giving it to charity to share your bounty.\n4. You're considering health care and long-term care\nMany retirees have high health-care costs. Medicare is a pretty good deal, but it doesn't cover everything. A health savings account is a tax-advantaged way to save for copayments, deductibles, vision care, and dental care. If you are eligible for a health savings account with your current health insurance, and if your retirement accounts are in good shape, consider maxing out your HSA contribution. The funds should roll over and be in place for you when you retire. The maximum HSA contribution for 2021 is $3600 for an individual and $7200 for a married couple filing jointly.\nLong-term care is especially expensive, whether it involves help at home, assisted living, or a skilled nursing facility. Long-term care insurance is available and is relatively inexpensive the younger that you are. If your basic retirement needs are covered, buying a long-term care policy instead of making a 401(k) contribution may be a good bet.\nBy all means, maximize your 401(k) contribution if it makes sense, and participate just enough to get any employer match (free money!). But if you find yourself identifying with any of the points above, you may want to consider saving for retirement in a different way, at least for now.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889224651,"gmtCreate":1631152589673,"gmtModify":1631890162219,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/889224651","repostId":"2166392072","repostType":4,"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":698273527,"gmtCreate":1640426196986,"gmtModify":1640426732815,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698273527","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":1642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693726308,"gmtCreate":1640084750823,"gmtModify":1640084751192,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693726308","repostId":"2193598841","repostType":4,"repost":{"id":"2193598841","kind":"news","pubTimestamp":1640084400,"share":"https://ttm.financial/m/news/2193598841?lang=&edition=full","pubTime":"2021-12-21 19:00","market":"us","language":"en","title":"China Online Education Group Announces Receipt of NYSE Non-Compliance Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2193598841","media":"StreetInsider","summary":"SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"51Talk,\" or the \"Compa","content":"<p>SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"<a href=\"https://laohu8.com/S/COE\">51Talk</a>,\" or the \"Company\") (NYSE: COE) today announced that it has received a letter dated December 20, 2021 (the \"Letter\") from the New York Stock Exchange (the \"NYSE\"), notifying the Company that it is below compliance standards due to the Company's total market capitalization and stockholders' equity.</p>\n<p>Pursuant to applicable NYSE continued listing standards, a company would be considered \"below criteria\" by the NYSE if its total market capitalization is less than US$50 million over a 30 trading-day period and its stockholders' equity is less than US$50 million. A review of the current financial condition of the Company by the NYSE shows that, as of December 17, 2021, the Company's 30 trading-day average market capitalization was approximately US$39.3 million and its last reported stockholders' equity as of June 30, 2021 was approximately negative US$134.2 million. Accordingly, the Company is now subject to the procedures as set forth in Sections 801 and 802 of the NYSE Listed Company Manual, and is required to respond within 90 days of the Letter with a business plan that demonstrates compliance with the continued listing standard within 18 months of receipt of the Letter. The business plan will be reviewed for final disposition by the Listings Operations Committee of the NYSE.</p>\n<p>To address this issue, the Company intends to comply with the applicable procedures and is considering its options to regain compliance.</p>\n<p><b>Safe Harbor Statement</b></p>\n<p>This press release contains statements that may constitute \"forward-looking\" statements which are made pursuant to the \"safe harbor\" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as \"will,\" \"expects,\" \"anticipates,\" \"aims,\" \"future,\" \"intends,\" \"plans,\" \"believes,\" \"estimates,\" \"likely to,\" and similar statements. 51Talk may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (\"SEC\"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about 51Talk's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in 51Talk's filings with the SEC. All information provided in this press release is as of the date of this press release, and 51Talk does not undertake any obligation to update any forward-looking statement, except as required under applicable law.</p>\n<p><b>About China Online Education Group</b></p>\n<p>China Online Education Group (NYSE: COE) is a leading online education platform in China, with core expertise in English education. The Company's mission is to make quality education accessible and affordable. The Company's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Company connects its students with a large pool of highly qualified foreign teachers that it assembled using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students.</p>\n<p><b>For investor and media inquiries, please contact:</b></p>\n<p>China Online Education GroupInvestor Relationsir@51talk.com</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Online Education Group Announces Receipt of NYSE Non-Compliance Letter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Online Education Group Announces Receipt of NYSE Non-Compliance Letter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19376369><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"51Talk,\" or the \"Company\") (NYSE: COE) today announced that it has received a letter dated December 20, 2021 (the \"Letter\"...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19376369\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COE":"51TALK","BK4204":"教育服务"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19376369","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193598841","content_text":"SHENZHEN, China, Dec. 21, 2021 /PRNewswire/ -- China Online Education Group (\"51Talk,\" or the \"Company\") (NYSE: COE) today announced that it has received a letter dated December 20, 2021 (the \"Letter\") from the New York Stock Exchange (the \"NYSE\"), notifying the Company that it is below compliance standards due to the Company's total market capitalization and stockholders' equity.\nPursuant to applicable NYSE continued listing standards, a company would be considered \"below criteria\" by the NYSE if its total market capitalization is less than US$50 million over a 30 trading-day period and its stockholders' equity is less than US$50 million. A review of the current financial condition of the Company by the NYSE shows that, as of December 17, 2021, the Company's 30 trading-day average market capitalization was approximately US$39.3 million and its last reported stockholders' equity as of June 30, 2021 was approximately negative US$134.2 million. Accordingly, the Company is now subject to the procedures as set forth in Sections 801 and 802 of the NYSE Listed Company Manual, and is required to respond within 90 days of the Letter with a business plan that demonstrates compliance with the continued listing standard within 18 months of receipt of the Letter. The business plan will be reviewed for final disposition by the Listings Operations Committee of the NYSE.\nTo address this issue, the Company intends to comply with the applicable procedures and is considering its options to regain compliance.\nSafe Harbor Statement\nThis press release contains statements that may constitute \"forward-looking\" statements which are made pursuant to the \"safe harbor\" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as \"will,\" \"expects,\" \"anticipates,\" \"aims,\" \"future,\" \"intends,\" \"plans,\" \"believes,\" \"estimates,\" \"likely to,\" and similar statements. 51Talk may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (\"SEC\"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about 51Talk's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in 51Talk's filings with the SEC. All information provided in this press release is as of the date of this press release, and 51Talk does not undertake any obligation to update any forward-looking statement, except as required under applicable law.\nAbout China Online Education Group\nChina Online Education Group (NYSE: COE) is a leading online education platform in China, with core expertise in English education. The Company's mission is to make quality education accessible and affordable. The Company's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Company connects its students with a large pool of highly qualified foreign teachers that it assembled using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students.\nFor investor and media inquiries, please contact:\nChina Online Education GroupInvestor Relationsir@51talk.com","news_type":1,"symbols_score_info":{"COE":0.9}},"isVote":1,"tweetType":1,"viewCount":2193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847484121,"gmtCreate":1636546004712,"gmtModify":1636546004866,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/847484121","repostId":"1153527139","repostType":4,"repost":{"id":"1153527139","kind":"news","pubTimestamp":1636545864,"share":"https://ttm.financial/m/news/1153527139?lang=&edition=full","pubTime":"2021-11-10 20:04","market":"us","language":"en","title":"Tesla Further Extends Delivery Time For Model Y Standard Range In China","url":"https://stock-news.laohu8.com/highlight/detail?id=1153527139","media":"Benzinga","summary":"Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in Chi","content":"<p><b>Tesla</b>&nbsp;<b>Inc’s</b>&nbsp;mid-size sports utility vehicle&nbsp;<b>ModelY</b>&nbsp;would now take even longer with deliveries in China, the electric vehicle maker’s website shows.</p>\n<p><b>What Happened:</b>The delivery time for the $43,200 Model Y standard range is now stretched to 10-14 weeks, from the earlier&nbsp;6-10 weeks range.</p>\n<p>The delivery for the Long Range and the Performance variant is estimated to take place in the fourth quarter; cnEVpost first&nbsp;reported&nbsp;on the development.</p>\n<p><b>Why It Matters:</b>Tesla launched the locally made Model Y standard range in July and started customer deliveries on August 26. The entry-level variant of Model Y uses CATL's more affordable lithium iron phosphate batteries.</p>\n<p>The&nbsp;<b>Elon</b>&nbsp;<b>Musk</b>-led company&nbsp;sold 54,391 electric vehicles&nbsp;to dealers in China in October, a rise of 348% on a year-on-year basis, as per China Passenger Car Association.</p>\n<p><b>Price Action:</b>Tesla shares closed 11.99% lower at $1,023.50 a share on Tuesday.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Further Extends Delivery Time For Model Y Standard Range In China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Further Extends Delivery Time For Model Y Standard Range In China\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 20:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in China, the electric vehicle maker’s website shows.\nWhat Happened:The delivery time for the $43,200 ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153527139","content_text":"Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in China, the electric vehicle maker’s website shows.\nWhat Happened:The delivery time for the $43,200 Model Y standard range is now stretched to 10-14 weeks, from the earlier 6-10 weeks range.\nThe delivery for the Long Range and the Performance variant is estimated to take place in the fourth quarter; cnEVpost first reported on the development.\nWhy It Matters:Tesla launched the locally made Model Y standard range in July and started customer deliveries on August 26. The entry-level variant of Model Y uses CATL's more affordable lithium iron phosphate batteries.\nThe Elon Musk-led company sold 54,391 electric vehicles to dealers in China in October, a rise of 348% on a year-on-year basis, as per China Passenger Car Association.\nPrice Action:Tesla shares closed 11.99% lower at $1,023.50 a share on Tuesday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":445,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":817831701,"gmtCreate":1630928876103,"gmtModify":1631890162223,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/817831701","repostId":"1143325200","repostType":4,"repost":{"id":"1143325200","kind":"news","pubTimestamp":1630882610,"share":"https://ttm.financial/m/news/1143325200?lang=&edition=full","pubTime":"2021-09-06 06:56","market":"us","language":"en","title":"GameStop, Moderna, Home Depot, Kroger, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1143325200","media":"Barrons","summary":"U.S. stock and bond markets are closed on Monday for Labor Day. The holiday-shortened week then feat","content":"<p>U.S. stock and bond markets are closed on Monday for Labor Day. The holiday-shortened week then features several notable company updates and economic data releases.</p>\n<p>GameStop and Lululemon Athletica release quarterly results on Wednesday, followed by International Paper on Thursday and Kroger on Friday. Analog Devices—fresh off of its&nbsp;$21 billion acquisition of Maxim Integrated Products—will host an investor day on Wednesday. Moderna, Danaher, and Home Depot managements will also speak with investors on Thursday. Finally, Albemarle&nbsp;hosts&nbsp;an investor day on Friday.</p>\n<p>The economic data highlight of the week will be Friday’s August producer price index from the Bureau of Labor Statistics. Economists’ consensus estimate is for a 0.6% monthly rise in the headline index, and a 0.5% increase for the core PPI—which leaves out more volatile food and energy prices. Both the core and headline indexes rose 1% in July. The August consumer price index will be out the following week, on Sept. 14.</p>\n<p>On Tuesday, the Federal Reserve will release its latest beige book, full of updates on economic, hiring, and business conditions in each of the dozen central bank districts. The European Central Bank also announces a monetary-policy decision on Thursday, but is widely expected to hold its target interest rate at its current level of negative 0.5%.</p>\n<p><b>Monday 9/6</b></p>\n<p>Stock and fixed-income markets are closed in observance of Labor Day.</p>\n<p><b>Tuesday 9/7</b></p>\n<p>Casey’s General Stores and Coupa Software announce earnings.</p>\n<p><b>Wednesday 9/8</b></p>\n<p>Copart, GameStop, and Lululemon Athletica release quarterly results.</p>\n<p>Analog Devices hosts a conference call to discuss its capital-allocation plans and update its outlook for fiscal 2021. The company recently closed its $21 billion acquisition of Maxim Integrated Products.</p>\n<p>Global Payments, Johnson Controls International, and ResMed hold virtual investor days.</p>\n<p>The Bureau of Labor Statistics releases the Job Openings and Labor Turnover Survey. Consensus estimate is for 10 million job openings on the last business day of July. In June, there were 10.1 million openings, the fourth consecutive monthly record.</p>\n<p>The Federal Reserve reports consumer credit data for July. Total outstanding consumer debt increased by $37.7 billion to a record $4.32 trillion in June. For the second quarter, consumer credit rose at a seasonally adjusted annual rate of 8.8%, reflecting pent-up demand.</p>\n<p>The Federal Reserve releases the beige book for the sixth of eight times this year. The report summarizes current economic conditions among the 12 Federal Reserve districts.</p>\n<p><b>Thursday 9/9</b></p>\n<p>Home Depot hosts a conference call to discuss its ESG strategy, led by Ron Jarvis, the company’s chief sustainability officer.</p>\n<p>Moderna hosts its fifth annual R&amp;D day to discuss vaccines in the company’s pipeline. CEO Stéphane Bancel will be among the presenters.</p>\n<p>Danaher holds an investor and analyst meeting, hosted by its CEO Rainer Blair.</p>\n<p>International Paper, Synchrony Financial, and Willis Towers Watson hold investor days.</p>\n<p>The European Central Bank announces its monetary-policy decision. The ECB is expected to keep its key interest rate unchanged at minus 0.5%.</p>\n<p>The Department of Labor reports initial jobless claims for the week ending on Sept. 4. In August, claims averaged 355,000 a week, the lowest since the pandemic’s onset. This will also be the last week that the extra $300 from federal enhanced unemployment benefits is available. They are set to expire by Sept. 6.</p>\n<p><b>Friday 9/10</b></p>\n<p>The BLS reports the producer price index for August. Economists forecast a 0.6% monthly rise along with a 0.5% increase for the core PPI, which excludes volatile food and energy prices. Both jumped 1% in July.</p>\n<p>Kroger holds a conference calls to discuss earnings.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop, Moderna, Home Depot, Kroger, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop, Moderna, Home Depot, Kroger, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-06 06:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/gamestop-moderna-home-depot-kroger-and-other-stocks-for-investors-to-watch-this-week-51630853023?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock and bond markets are closed on Monday for Labor Day. The holiday-shortened week then features several notable company updates and economic data releases.\nGameStop and Lululemon Athletica ...</p>\n\n<a href=\"https://www.barrons.com/articles/gamestop-moderna-home-depot-kroger-and-other-stocks-for-investors-to-watch-this-week-51630853023?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.",".DJI":"道琼斯","KR":"克罗格",".IXIC":"NASDAQ Composite","HD":"家得宝",".SPX":"S&P 500 Index","GME":"游戏驿站"},"source_url":"https://www.barrons.com/articles/gamestop-moderna-home-depot-kroger-and-other-stocks-for-investors-to-watch-this-week-51630853023?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143325200","content_text":"U.S. stock and bond markets are closed on Monday for Labor Day. The holiday-shortened week then features several notable company updates and economic data releases.\nGameStop and Lululemon Athletica release quarterly results on Wednesday, followed by International Paper on Thursday and Kroger on Friday. Analog Devices—fresh off of its $21 billion acquisition of Maxim Integrated Products—will host an investor day on Wednesday. Moderna, Danaher, and Home Depot managements will also speak with investors on Thursday. Finally, Albemarle hosts an investor day on Friday.\nThe economic data highlight of the week will be Friday’s August producer price index from the Bureau of Labor Statistics. Economists’ consensus estimate is for a 0.6% monthly rise in the headline index, and a 0.5% increase for the core PPI—which leaves out more volatile food and energy prices. Both the core and headline indexes rose 1% in July. The August consumer price index will be out the following week, on Sept. 14.\nOn Tuesday, the Federal Reserve will release its latest beige book, full of updates on economic, hiring, and business conditions in each of the dozen central bank districts. The European Central Bank also announces a monetary-policy decision on Thursday, but is widely expected to hold its target interest rate at its current level of negative 0.5%.\nMonday 9/6\nStock and fixed-income markets are closed in observance of Labor Day.\nTuesday 9/7\nCasey’s General Stores and Coupa Software announce earnings.\nWednesday 9/8\nCopart, GameStop, and Lululemon Athletica release quarterly results.\nAnalog Devices hosts a conference call to discuss its capital-allocation plans and update its outlook for fiscal 2021. The company recently closed its $21 billion acquisition of Maxim Integrated Products.\nGlobal Payments, Johnson Controls International, and ResMed hold virtual investor days.\nThe Bureau of Labor Statistics releases the Job Openings and Labor Turnover Survey. Consensus estimate is for 10 million job openings on the last business day of July. In June, there were 10.1 million openings, the fourth consecutive monthly record.\nThe Federal Reserve reports consumer credit data for July. Total outstanding consumer debt increased by $37.7 billion to a record $4.32 trillion in June. For the second quarter, consumer credit rose at a seasonally adjusted annual rate of 8.8%, reflecting pent-up demand.\nThe Federal Reserve releases the beige book for the sixth of eight times this year. The report summarizes current economic conditions among the 12 Federal Reserve districts.\nThursday 9/9\nHome Depot hosts a conference call to discuss its ESG strategy, led by Ron Jarvis, the company’s chief sustainability officer.\nModerna hosts its fifth annual R&D day to discuss vaccines in the company’s pipeline. CEO Stéphane Bancel will be among the presenters.\nDanaher holds an investor and analyst meeting, hosted by its CEO Rainer Blair.\nInternational Paper, Synchrony Financial, and Willis Towers Watson hold investor days.\nThe European Central Bank announces its monetary-policy decision. The ECB is expected to keep its key interest rate unchanged at minus 0.5%.\nThe Department of Labor reports initial jobless claims for the week ending on Sept. 4. In August, claims averaged 355,000 a week, the lowest since the pandemic’s onset. This will also be the last week that the extra $300 from federal enhanced unemployment benefits is available. They are set to expire by Sept. 6.\nFriday 9/10\nThe BLS reports the producer price index for August. Economists forecast a 0.6% monthly rise along with a 0.5% increase for the core PPI, which excludes volatile food and energy prices. Both jumped 1% in July.\nKroger holds a conference calls to discuss earnings.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"GME":0.9,"HD":0.9,"KR":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":699700391,"gmtCreate":1639885504725,"gmtModify":1639885504895,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699700391","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://ttm.financial/m/news/1122414343?lang=&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p>\n<p>Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p>\n<p>Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p>\n<p><a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p>\n<p>Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p>\n<p>Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p>\n<p>Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p>\n<p>Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 11:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4568":"美国抗疫概念","CERN":"美国塞纳","BK4533":"AQR资本管理(全球第二大对冲基金)","ARNA":"阿里那","PFE":"辉瑞","ORCL":"甲骨文","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals  dominated with a ~83.8% rise after Pfizer  agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner  also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle  for the electronic-medical-records company.\nVaccine developer, Novavax  jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical  posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences  added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"ARNA":0.9,"CERN":0.9,"ORCL":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1513,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607553550,"gmtCreate":1639568276415,"gmtModify":1639568277039,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607553550","repostId":"2191074962","repostType":4,"repost":{"id":"2191074962","kind":"highlight","pubTimestamp":1639567600,"share":"https://ttm.financial/m/news/2191074962?lang=&edition=full","pubTime":"2021-12-15 19:26","market":"us","language":"en","title":"1 Unstoppable Vanguard ETF That Could Double Your Money in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2191074962","media":"Motley Fool","summary":"Over time, you could earn hundreds of thousands of dollars or more with this ETF.","content":"<p>The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new year off with a bang.</p>\n<p>With countless stocks and funds to choose from, though, it can sometimes be overwhelming to pick the right <a href=\"https://laohu8.com/S/AONE.U\">one</a>.</p>\n<p>There's one exchange-traded fund (ETF), however, that's lower-risk and also packs a punch: the <b>Vanguard S&amp;P 500 ETF</b> (NYSEMKT:VOO). Not only does this ETF make a smart long-term investment, but by investing now, you could also potentially double your money in 2022.</p>\n<h2>Why invest in an S&amp;P 500 ETF?</h2>\n<p>The Vanguard S&amp;P 500 ETF aims to mirror the performance of the <b>S&amp;P 500</b> index itself. It contains stocks from the same 500 companies, and it's designed to earn roughly the same returns as the index.</p>\n<p>This ETF has several advantages, too. For one, it's very likely to survive stock market turbulence. The S&amp;P 500 itself does experience short-term volatility, but it's always recovered from every downturn it's ever faced.</p>\n<p>Nobody knows for certain if a market crash is looming, but some experts believe we'll see a downturn in 2022. If that happens, an S&amp;P 500 ETF can be a smart investment to have in your portfolio. Although it may take a hit in the short term, it's almost guaranteed to bounce back eventually.</p>\n<p>The Vanguard S&amp;P 500 ETF is also a powerhouse investment that can help your savings grow relatively quickly. Historically, the S&amp;P 500 has earned an average annual return of around 10% per year. Some years you may earn less than that, while other years (such as 2020 and 2021), you could earn significantly higher returns.</p>\n<h2>How to double your money in 2022</h2>\n<p>When investing in the stock market, time is your most valuable resource. One of the best ways to increase your savings is to invest consistently and give your money as much time as possible to grow.</p>\n<p>Say you invest $1,000 in the Vanguard S&amp;P 500 ETF on January 1, 2022. Let's also say you continue investing $100 per month, and you're earning a 10% average annual rate of return. By the end of the year, you'll have a total of around $2,300.</p>\n<p>Of course, nothing is guaranteed when it comes to the stock market. If 2022 is a rough year for the market, you may earn lower returns. Over the long run, though, you're likely to see positive returns and accumulate a substantial amount of money as long as you continue investing regularly.</p>\n<p>For instance, say that you continue investing $100 per month in the Vanguard S&amp;P 500 ETF. After 10 years, you'll have close to $28,000, assuming you're still earning a 10% average annual return. In 30 years, you'll have accumulated around $215,000.</p>\n<p>Investing in the stock market can be a fantastic way to generate wealth, and the Vanguard S&amp;P 500 ETF is a strong choice for many reasons. Regardless of where you invest, getting started now and investing consistently can make it easier to make money in the stock market.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Unstoppable Vanguard ETF That Could Double Your Money in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Unstoppable Vanguard ETF That Could Double Your Money in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 19:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/15/1-unstoppable-vanguard-etf-double-your-money-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/15/1-unstoppable-vanguard-etf-double-your-money-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","IVV":"标普500指数ETF","BK4559":"巴菲特持仓","BK4504":"桥水持仓","SPXU":"三倍做空标普500ETF","SPY":"标普500ETF","BK4550":"红杉资本持仓",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","BK4534":"瑞士信贷持仓","SH":"标普500反向ETF","OEF":"标普100指数ETF-iShares","OEX":"标普100"},"source_url":"https://www.fool.com/investing/2021/12/15/1-unstoppable-vanguard-etf-double-your-money-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191074962","content_text":"The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new year off with a bang.\nWith countless stocks and funds to choose from, though, it can sometimes be overwhelming to pick the right one.\nThere's one exchange-traded fund (ETF), however, that's lower-risk and also packs a punch: the Vanguard S&P 500 ETF (NYSEMKT:VOO). Not only does this ETF make a smart long-term investment, but by investing now, you could also potentially double your money in 2022.\nWhy invest in an S&P 500 ETF?\nThe Vanguard S&P 500 ETF aims to mirror the performance of the S&P 500 index itself. It contains stocks from the same 500 companies, and it's designed to earn roughly the same returns as the index.\nThis ETF has several advantages, too. For one, it's very likely to survive stock market turbulence. The S&P 500 itself does experience short-term volatility, but it's always recovered from every downturn it's ever faced.\nNobody knows for certain if a market crash is looming, but some experts believe we'll see a downturn in 2022. If that happens, an S&P 500 ETF can be a smart investment to have in your portfolio. Although it may take a hit in the short term, it's almost guaranteed to bounce back eventually.\nThe Vanguard S&P 500 ETF is also a powerhouse investment that can help your savings grow relatively quickly. Historically, the S&P 500 has earned an average annual return of around 10% per year. Some years you may earn less than that, while other years (such as 2020 and 2021), you could earn significantly higher returns.\nHow to double your money in 2022\nWhen investing in the stock market, time is your most valuable resource. One of the best ways to increase your savings is to invest consistently and give your money as much time as possible to grow.\nSay you invest $1,000 in the Vanguard S&P 500 ETF on January 1, 2022. Let's also say you continue investing $100 per month, and you're earning a 10% average annual rate of return. By the end of the year, you'll have a total of around $2,300.\nOf course, nothing is guaranteed when it comes to the stock market. If 2022 is a rough year for the market, you may earn lower returns. Over the long run, though, you're likely to see positive returns and accumulate a substantial amount of money as long as you continue investing regularly.\nFor instance, say that you continue investing $100 per month in the Vanguard S&P 500 ETF. After 10 years, you'll have close to $28,000, assuming you're still earning a 10% average annual return. In 30 years, you'll have accumulated around $215,000.\nInvesting in the stock market can be a fantastic way to generate wealth, and the Vanguard S&P 500 ETF is a strong choice for many reasons. Regardless of where you invest, getting started now and investing consistently can make it easier to make money in the stock market.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,".SPX":0.9,"ETF":0.9,"ESmain":0.9,"IVV":0.9,"OEF":0.9,"OEX":0.9,"SDS":0.9,"SH":0.9,"SPXU":0.9,"SPY":0.9,"SSO":0.9,"UPRO":0.9}},"isVote":1,"tweetType":1,"viewCount":2845,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607397508,"gmtCreate":1639486342125,"gmtModify":1639486342312,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/607397508","repostId":"2191937005","repostType":4,"repost":{"id":"2191937005","kind":"highlight","pubTimestamp":1639485464,"share":"https://ttm.financial/m/news/2191937005?lang=&edition=full","pubTime":"2021-12-14 20:37","market":"us","language":"en","title":"Got $1,500? 3 Growth Stocks to Buy That Could Double Your Money","url":"https://stock-news.laohu8.com/highlight/detail?id=2191937005","media":"Motley Fool","summary":"Investing is a long-term game in which growth stocks are the best option.","content":"<p>To double your investment with marijuana stocks, <a href=\"https://laohu8.com/S/AONE.U\">one</a> needs a strong appetite for risk and lots of patience. The industry is still in its nascent stage and sees ups and downs, and the drug is still illegal federally in the U.S. But even with a limited legal market, these three cannabis multi-state operators (MSO) are performing exceptionally well.</p>\n<p>New York-based&nbsp;<b>Columbia Care</b>&nbsp;(OTC:CCHWF), Colorado-based&nbsp;<b>GrowGeneration</b>&nbsp;(NASDAQ:GRWG), and Illinois-based <b>Cresco Labs</b>&nbsp;(OTC:CRLBF) are smaller in size but have the potential to shine as the industry expands. If you have $1,500 spare money left after paying all your bills, let me tell you why these three growth stocks are your best bet to invest in now and grow your money in the long run.</p>\n<h2>1. Columbia Care</h2>\n<p>Even with a market cap of just $1.1 billion, this marijuana company is preparing itself to give tough competition to the bigger MSOs. Columbia Care operates 131 facilities, out of which 99 are retail stores. The company has grown itself with smart acquisitions. It recently acquired Colorado-based Medicine Man, and in June it completed its buyout of Green Leaf Medical, strengthening its positions in Colorado and the Mid-Atlantic.</p>\n<p>Although these acquisitions are burdening its short-term cost structure, they will bring in profits in the coming years. Columbia Care also targets limited license markets that are careful of how many licenses they issue. This helps the company garner a loyal customer base for its brands.</p>\n<p>These strategies led to another great quarter, with revenue surging 144% year over year to $132 million in the third quarter of 2021. It also recorded an outstanding jump of 634% in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $31 million from Q3 2020.&nbsp;During the same period ended Sept. 30, it also grew its gross profit margin to 49% from 39% a year ago.&nbsp;Besides the bigger markets of California and Colorado, limited license markets like Massachusetts, Ohio, Pennsylvania, Illinois, Maryland, and Virginia also contributed to the&nbsp;performance.&nbsp;</p>\n<p>Columbia Care's management expects some recent headwinds (delays in the opening of dispensaries and in the implementation of recreational markets in the states that recently legalized it) to affect full-year results. The revised guidance now includes revenue to come in the range of $470 million to $485 million, adjusted EBITDA in the range of $85 million to $95 million, and adjusted gross profit margin to be around 46% for 2021. </p>\n<p>The company isn't profitable yet, but with wise acquisition strategies and expansion plans, it won't be too long until it starts earning profits.</p>\n<h2>2. GrowGeneration</h2>\n<p>GrowGeneration is not a pure-play cannabis company but a pick-and-shovel cannabis company. This hydroponics supplier sells products and equipment used by marijuana growers. With a market cap of just $977 million, the company has a wide network of 62 stores nationally and has managed to grow its revenue and profits by an outstanding amount. In the first nine months of 2021, its revenue has surged to $331 million compared with $131 million in the same period a year ago. Net profits have also increased to $16.8 million from $3.8 million for the nine months ended Sept. 30, 2020. The company expects to further add $15 million in revenue annually from its recent acquisition of Washington-based Hoagtech Hydroponics. </p>\n<p>Projecting the same headwinds as Columbia Care, GrowGeneration also revised its 2021 guidance. It now expects full-year 2021 revenue to come in the range of $435 million to $440 million and adjusted EBITDA guidance to be in a range of $41 million to $43 million. It also&nbsp;plans to open 15 to 20 more stores next&nbsp;year. Management believes these headwinds will sort out by the second half of 2022.&nbsp; If the company manages to hit the upper end of the guidance, that will be a 128% increase from its 2020 revenue -- impressive growth for a small company.&nbsp;</p>\n<h2>3. Cresco Labs</h2>\n<p>This pure-play cannabis grower doesn't have a vast presence yet, but with just 40 stores, it is making a mark in the domestic markets. In its recent third quarter of 2021, ended Sept. 30, total revenue surged 41% year over year to $215 million. </p>\n<p>Cresco also follows the same strategy of targeting limited license markets like Pennsylvania, Illinois, and Ohio. This strategy has also benefited Cresco, helping it build a loyal customer base for its popular brands like Mindy's Edibles, High Supply, and more that brought in $106.2 million in retail revenue in Q3 (the rest came in from wholesale revenue). </p>\n<p>It has mostly taken advantage of the new recreational market in Illinois that has brought in huge sales since the state legalized it in January 2020. As of November, the state had already broken its record last year of $1 billion in recreational cannabis sales. </p>\n<p>The company recorded adjusted EBITDA of $56 million, compared with $40 million in the year-ago quarter. A net loss of $263,000 in Q3 came in as a disappointment, compared with a net profit of $25 million in Q3 2020, due to a noncash impairment charge of around $290 million. </p>\n<p>Management stated that this charge was related to the company's \"exit from third-party distribution agreements in California.\" But the good news is despite a net loss, Cresco reaffirmed its 2021 guidance. It still expects revenue to come in the range of $235 million to $245 million, adjusted EBITDA margin of 30% for 2021, and a gross profit margin above 50% for the rest of 2021.&nbsp;</p>\n<p>Do not be disheartened by the recent downfall of marijuana stocks. I believe this presents a lucrative opportunity as growth stocks take time to show their full potential. As the burgeoning and recession-resistant cannabis industry expands, so will these three companies. Analysts see upsides of 126%, 210%, and 106% for GrowGeneration, Columbia Care, and Cresco Labs' stock, respectively,&nbsp;in the next 12 months. All three pot stocks are trading below their 52-week highs, making it the right time to put in your money.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,500? 3 Growth Stocks to Buy That Could Double Your Money</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,500? 3 Growth Stocks to Buy That Could Double Your Money\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 20:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/got-1500-3-growth-stocks-to-buy-that-could-double/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To double your investment with marijuana stocks, one needs a strong appetite for risk and lots of patience. The industry is still in its nascent stage and sees ups and downs, and the drug is still ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/got-1500-3-growth-stocks-to-buy-that-could-double/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRWG":"GrowGeneration Corp.","BK4083":"家庭装潢零售","BK4557":"大麻股"},"source_url":"https://www.fool.com/investing/2021/12/14/got-1500-3-growth-stocks-to-buy-that-could-double/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191937005","content_text":"To double your investment with marijuana stocks, one needs a strong appetite for risk and lots of patience. The industry is still in its nascent stage and sees ups and downs, and the drug is still illegal federally in the U.S. But even with a limited legal market, these three cannabis multi-state operators (MSO) are performing exceptionally well.\nNew York-based Columbia Care (OTC:CCHWF), Colorado-based GrowGeneration (NASDAQ:GRWG), and Illinois-based Cresco Labs (OTC:CRLBF) are smaller in size but have the potential to shine as the industry expands. If you have $1,500 spare money left after paying all your bills, let me tell you why these three growth stocks are your best bet to invest in now and grow your money in the long run.\n1. Columbia Care\nEven with a market cap of just $1.1 billion, this marijuana company is preparing itself to give tough competition to the bigger MSOs. Columbia Care operates 131 facilities, out of which 99 are retail stores. The company has grown itself with smart acquisitions. It recently acquired Colorado-based Medicine Man, and in June it completed its buyout of Green Leaf Medical, strengthening its positions in Colorado and the Mid-Atlantic.\nAlthough these acquisitions are burdening its short-term cost structure, they will bring in profits in the coming years. Columbia Care also targets limited license markets that are careful of how many licenses they issue. This helps the company garner a loyal customer base for its brands.\nThese strategies led to another great quarter, with revenue surging 144% year over year to $132 million in the third quarter of 2021. It also recorded an outstanding jump of 634% in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to $31 million from Q3 2020. During the same period ended Sept. 30, it also grew its gross profit margin to 49% from 39% a year ago. Besides the bigger markets of California and Colorado, limited license markets like Massachusetts, Ohio, Pennsylvania, Illinois, Maryland, and Virginia also contributed to the performance. \nColumbia Care's management expects some recent headwinds (delays in the opening of dispensaries and in the implementation of recreational markets in the states that recently legalized it) to affect full-year results. The revised guidance now includes revenue to come in the range of $470 million to $485 million, adjusted EBITDA in the range of $85 million to $95 million, and adjusted gross profit margin to be around 46% for 2021. \nThe company isn't profitable yet, but with wise acquisition strategies and expansion plans, it won't be too long until it starts earning profits.\n2. GrowGeneration\nGrowGeneration is not a pure-play cannabis company but a pick-and-shovel cannabis company. This hydroponics supplier sells products and equipment used by marijuana growers. With a market cap of just $977 million, the company has a wide network of 62 stores nationally and has managed to grow its revenue and profits by an outstanding amount. In the first nine months of 2021, its revenue has surged to $331 million compared with $131 million in the same period a year ago. Net profits have also increased to $16.8 million from $3.8 million for the nine months ended Sept. 30, 2020. The company expects to further add $15 million in revenue annually from its recent acquisition of Washington-based Hoagtech Hydroponics. \nProjecting the same headwinds as Columbia Care, GrowGeneration also revised its 2021 guidance. It now expects full-year 2021 revenue to come in the range of $435 million to $440 million and adjusted EBITDA guidance to be in a range of $41 million to $43 million. It also plans to open 15 to 20 more stores next year. Management believes these headwinds will sort out by the second half of 2022.  If the company manages to hit the upper end of the guidance, that will be a 128% increase from its 2020 revenue -- impressive growth for a small company. \n3. Cresco Labs\nThis pure-play cannabis grower doesn't have a vast presence yet, but with just 40 stores, it is making a mark in the domestic markets. In its recent third quarter of 2021, ended Sept. 30, total revenue surged 41% year over year to $215 million. \nCresco also follows the same strategy of targeting limited license markets like Pennsylvania, Illinois, and Ohio. This strategy has also benefited Cresco, helping it build a loyal customer base for its popular brands like Mindy's Edibles, High Supply, and more that brought in $106.2 million in retail revenue in Q3 (the rest came in from wholesale revenue). \nIt has mostly taken advantage of the new recreational market in Illinois that has brought in huge sales since the state legalized it in January 2020. As of November, the state had already broken its record last year of $1 billion in recreational cannabis sales. \nThe company recorded adjusted EBITDA of $56 million, compared with $40 million in the year-ago quarter. A net loss of $263,000 in Q3 came in as a disappointment, compared with a net profit of $25 million in Q3 2020, due to a noncash impairment charge of around $290 million. \nManagement stated that this charge was related to the company's \"exit from third-party distribution agreements in California.\" But the good news is despite a net loss, Cresco reaffirmed its 2021 guidance. It still expects revenue to come in the range of $235 million to $245 million, adjusted EBITDA margin of 30% for 2021, and a gross profit margin above 50% for the rest of 2021. \nDo not be disheartened by the recent downfall of marijuana stocks. I believe this presents a lucrative opportunity as growth stocks take time to show their full potential. As the burgeoning and recession-resistant cannabis industry expands, so will these three companies. Analysts see upsides of 126%, 210%, and 106% for GrowGeneration, Columbia Care, and Cresco Labs' stock, respectively, in the next 12 months. All three pot stocks are trading below their 52-week highs, making it the right time to put in your money.","news_type":1,"symbols_score_info":{"GRWG":0.9,"MSO":0.9}},"isVote":1,"tweetType":1,"viewCount":2181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872957498,"gmtCreate":1637404608224,"gmtModify":1637404608307,"author":{"id":"3580889175020769","authorId":"3580889175020769","name":"sockbuster","avatar":"https://static.tigerbbs.com/902e4c3353374f5915d6b7fecf6ec383","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580889175020769","authorIdStr":"3580889175020769"},"themes":[],"htmlText":"Pls likw","listText":"Pls likw","text":"Pls likw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/872957498","repostId":"2184842262","repostType":4,"repost":{"id":"2184842262","kind":"news","pubTimestamp":1637359018,"share":"https://ttm.financial/m/news/2184842262?lang=&edition=full","pubTime":"2021-11-20 05:56","market":"us","language":"en","title":"Nasdaq ends atop 16,000 mark for the first time on tech strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2184842262","media":"Reuters","summary":"(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in i","content":"<p>(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow to its fourth losing session in the last five.</p>\n<p>Both the Nasdaq and S&amp;P 500 index scored a winning week, up 1.2% and 0.3% respectively, after last week's declines snapped a five-week run of higher finishes.</p>\n<p>The Dow Jones Industrial Average's second-successive weekly loss - this one of 1.4% - wiped out the last of its November gains, extending the index's drop from a Nov. 8 record high to 2.3%.</p>\n<p>Friday's fall was caused by banking, energy and airline stocks slumping on fears that European countries, battling a resurgence of COVID-19 cases, could follow Austria in moving towards a full lockdown.</p>\n<p>Banking stocks fell 1.6%, tracking a drop in Treasury yields as investors snapped up safe-haven bonds. The S&amp;P energy index dropped 3.9%, the worst performing sector, as crude prices fell on demand implications.</p>\n<p>Carriers including Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp all dropped between 0.6% and 2.8%.</p>\n<p>\"It's a normal time to take risk off. And in this case, there's just so much liquidity that the market doesn't go down - just people take risk off by going into safe havens,\" said Jay Hatfield, chief executive of Infrastructure Capital Management in New York.</p>\n<p>Falling yields and safe-haven demand supported major technology stocks, which in turn lifted the Nasdaq.</p>\n<p>FAANG stocks, which have largely persevered through economic shocks since 2020, traded broadly higher. Netflix Inc gained along with other stay-at-home stocks.</p>\n<p>Chipmaker Nvidia Corp rose 4.1% to its third straight closing high, and the Philadelphia semiconductor index , up 0.3%, hit its third record closing high in four.</p>\n<p>The Dow Jones Industrial Average fell 268.97 points, or 0.75%, to 35,601.98; the S&amp;P 500 lost 6.58 points, or 0.14%, at 4,697.96; and the Nasdaq Composite added 63.73 points, or 0.4%, to 16,057.44.</p>\n<p>The S&amp;P 500 gyrated on Friday before slipping into negative territory, after a week in which retailers pushed it to a record finish the previous day.</p>\n<p>The S&amp;P consumer discretionary sector rose 0.3% to a closing peak for a second day in a row, after breaking its lifetime intraday high on Friday. This follows strong retail earnings this week and positive signs for holiday shopping.</p>\n<p>Lowe's Companies rose 0.9% to its third successive record close after reporting third-quarter results on Wednesday. Etsy Inc, which posted earnings earlier this month, achieved the same closing feat after finishing up 1.4%.</p>\n<p>\"Out of the Q3 earnings, one of the trends we have seen is the resounding strength of the U.S. consumer,\" said Jessica Bemer, portfolio manager at Easterly Investment Partners.</p>\n<p>\"We've heard it all through this week from retailers talking about the consumer coming back into the store, enjoying the shopping experience and getting ready for the holidays. It makes sense but it was really validated during earnings season.\"</p>\n<p>Profit-taking in names which gained earlier in the week led to drops of between 2.9% and 8.8% in Macy's Inc, Kohls Corp and Gap Inc.</p>\n<p>The information technology segment, up 0.8%, was the best performer on the S&amp;P 500.</p>\n<p>It was buoyed by Intuit Inc, which jumped 10.1% as brokerages lifted their price targets on the income tax software company after it beat quarterly estimates and raised forecasts.</p>\n<p>Volume on U.S. exchanges was 10.68 billion shares, compared with the 11.12 billion average for the full session over the last 20 trading days.</p>\n<p>The S&amp;P 500 posted 45 new 52-week highs and nine new lows; the Nasdaq Composite recorded 100 new highs and 309 new lows.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq ends atop 16,000 mark for the first time on tech strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq ends atop 16,000 mark for the first time on tech strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 05:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","COMP":"Compass, Inc.",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/us-stocks-nasdaq-ends-atop-215658565.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2184842262","content_text":"(Reuters) - The Nasdaq Composite Index closed above 16,000 points for the first time on Friday, in its second-straight record finish powered by technology stocks, while pandemic jitters sent the Dow to its fourth losing session in the last five.\nBoth the Nasdaq and S&P 500 index scored a winning week, up 1.2% and 0.3% respectively, after last week's declines snapped a five-week run of higher finishes.\nThe Dow Jones Industrial Average's second-successive weekly loss - this one of 1.4% - wiped out the last of its November gains, extending the index's drop from a Nov. 8 record high to 2.3%.\nFriday's fall was caused by banking, energy and airline stocks slumping on fears that European countries, battling a resurgence of COVID-19 cases, could follow Austria in moving towards a full lockdown.\nBanking stocks fell 1.6%, tracking a drop in Treasury yields as investors snapped up safe-haven bonds. The S&P energy index dropped 3.9%, the worst performing sector, as crude prices fell on demand implications.\nCarriers including Delta Air Lines, United Airlines and American Airlines, and cruiseliners Norwegian Cruise Line and Carnival Corp all dropped between 0.6% and 2.8%.\n\"It's a normal time to take risk off. And in this case, there's just so much liquidity that the market doesn't go down - just people take risk off by going into safe havens,\" said Jay Hatfield, chief executive of Infrastructure Capital Management in New York.\nFalling yields and safe-haven demand supported major technology stocks, which in turn lifted the Nasdaq.\nFAANG stocks, which have largely persevered through economic shocks since 2020, traded broadly higher. Netflix Inc gained along with other stay-at-home stocks.\nChipmaker Nvidia Corp rose 4.1% to its third straight closing high, and the Philadelphia semiconductor index , up 0.3%, hit its third record closing high in four.\nThe Dow Jones Industrial Average fell 268.97 points, or 0.75%, to 35,601.98; the S&P 500 lost 6.58 points, or 0.14%, at 4,697.96; and the Nasdaq Composite added 63.73 points, or 0.4%, to 16,057.44.\nThe S&P 500 gyrated on Friday before slipping into negative territory, after a week in which retailers pushed it to a record finish the previous day.\nThe S&P consumer discretionary sector rose 0.3% to a closing peak for a second day in a row, after breaking its lifetime intraday high on Friday. This follows strong retail earnings this week and positive signs for holiday shopping.\nLowe's Companies rose 0.9% to its third successive record close after reporting third-quarter results on Wednesday. Etsy Inc, which posted earnings earlier this month, achieved the same closing feat after finishing up 1.4%.\n\"Out of the Q3 earnings, one of the trends we have seen is the resounding strength of the U.S. consumer,\" said Jessica Bemer, portfolio manager at Easterly Investment Partners.\n\"We've heard it all through this week from retailers talking about the consumer coming back into the store, enjoying the shopping experience and getting ready for the holidays. It makes sense but it was really validated during earnings season.\"\nProfit-taking in names which gained earlier in the week led to drops of between 2.9% and 8.8% in Macy's Inc, Kohls Corp and Gap Inc.\nThe information technology segment, up 0.8%, was the best performer on the S&P 500.\nIt was buoyed by Intuit Inc, which jumped 10.1% as brokerages lifted their price targets on the income tax software company after it beat quarterly estimates and raised forecasts.\nVolume on U.S. exchanges was 10.68 billion shares, compared with the 11.12 billion average for the full session over the last 20 trading days.\nThe S&P 500 posted 45 new 52-week highs and nine new lows; the Nasdaq Composite recorded 100 new highs and 309 new lows.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"COMP":0.6}},"isVote":1,"tweetType":1,"viewCount":153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}